T	O
cell	O
priming	O
enhances	O
IL-4	B-DNA
gene	I-DNA
expression	O
by	O
increasing	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
.	O

The	O
repetitive	O
activation	O
of	O
T	B-cell_type
cells	I-cell_type
(	O
priming	O
)	O
enhances	O
the	O
expression	O
of	O
many	O
cytokines	B-protein
,	O
such	O
as	O
IL-4	O
,	O
but	O
not	O
others	O
,	O
such	O
as	O
IL-2	B-protein
.	O

Molecular	O
mechanisms	O
underlying	O
selective	O
expression	O
of	O
cytokines	B-protein
by	O
T	B-cell_type
cells	I-cell_type
remain	O
poorly	O
understood	O
.	O

Here	O
we	O
show	O
that	O
priming	O
of	O
CD4	B-cell_type
T	I-cell_type
cells	I-cell_type
selectively	O
enhances	O
IL-4	B-protein
expression	O
relative	O
to	O
IL-2	B-protein
expression	O
by	O
a	O
transcriptional	O
mechanism	O
involving	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
(	I-protein
NFAT	I-protein
)	I-protein
proteins	I-protein
.	O

As	O
detected	O
by	O
in	O
vivo	O
footprinting	O
,	O
priming	O
markedly	O
increases	O
the	O
activation-dependent	O
engagement	O
of	O
the	O
P0	B-DNA
and	O
P1	B-DNA
NFAT-binding	B-DNA
elements	I-DNA
of	O
the	O
IL-4	B-DNA
promoter	I-DNA
.	O

Moreover	O
,	O
each	O
proximal	B-DNA
P	I-DNA
element	I-DNA
is	O
essential	O
for	O
optimal	O
IL-4	B-DNA
promoter	I-DNA
activity	O
.	O

Activated	O
primed	O
CD4	B-cell_type
T	I-cell_type
cells	I-cell_type
contain	O
more	O
NFAT1	B-protein
and	O
support	O
greater	O
NFAT	B-protein
-directed	O
transcription	O
than	O
unprimed	O
CD4	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
while	O
activator	B-protein
protein	I-protein
1	I-protein
binding	O
and	O
activator	B-protein
protein	I-protein
1	I-protein
-mediated	O
transcription	O
by	O
both	O
cell	O
types	O
is	O
similar	O
.	O

Increased	O
expression	O
of	O
wild-type	O
NFAT1	B-protein
substantially	O
increases	O
IL-4	B-DNA
promoter	I-DNA
activity	O
in	O
unprimed	O
CD4	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
suggesting	O
NFAT1	B-protein
may	O
be	O
limiting	O
for	O
IL-4	B-protein
gene	O
expression	O
in	O
this	O
cell	O
type	O
.	O

Furthermore	O
,	O
a	O
truncated	O
form	O
of	O
NFAT1	B-protein
acts	O
as	O
a	O
dominant-negative	O
,	O
reducing	O
IL-4	B-DNA
promoter	I-DNA
activity	O
in	O
primed	O
CD4	B-cell_type
T	I-cell_type
cells	I-cell_type
and	O
confirming	O
the	O
importance	O
of	O
endogenous	B-protein
NFAT	I-protein
to	O
increased	O
IL-4	B-protein
gene	O
expression	O
by	O
effector	O
T	O
cells	O
.	O

NFAT1	B-protein
appears	O
to	O
be	O
the	O
major	O
NFAT	B-protein
family	I-protein
member	I-protein
responsible	O
for	O
the	O
initial	O
increased	O
expression	O
of	O
IL-4	B-protein
by	O
primed	O
CD4	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
I	NULL
.	NULL

:	NULL
CURIOX	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
Accelerating	NULL
Life	NULL
Sciences	NULL
So	NULL
meJournal	NULL
o	NULL
T	NULL
Cell	NULL
Priming	NULL
Enhances	NULL
IL-4	NULL
Gene	NULL
*	NULL
Immunol	NULL
Expression	NULL
by	NULL
Increasing	NULL
Nuclear	NULL
Factor	NULL
of	NULL
unoiogy	NULL
Activated	NULL
T	NULL
Cells	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
_	NULL
Randy	NULL
Q.	NULL
Cron	NULL
,	NULL
Susan	NULL
J.	NULL
Bort	NULL
,	NULL
Yunxia	NULL
Wang	NULL
,	NULL
Mark	NULL
W.	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Brunvand	NULL
and	NULL
David	NULL
B.	NULL
Lewis	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:860-870	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/2/860	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
83	NULL
articles	NULL
,	NULL
50	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/2/860	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
T	NULL
Cell	NULL
Priming	NULL
Enhances	NULL
IL-4	NULL
Gene	NULL
Expression	NULL
by	NULL
Increasing	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
!	NULL

Randy	NULL
Q.	NULL
Cron	NULL
,	NULL
*	NULL
Susan	NULL
J.	NULL
Bort	NULL
,	NULL
*	NULL
Yunxia	NULL
Wang	NULL
,	NULL
*	NULL
Mark	NULL
W.	NULL
Brunvand	NULL
,	NULL
``	NULL
and	NULL
David	NULL
B.	NULL
Lewis®*	NULL
The	NULL
repetitive	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
priming	NULL
)	NULL
enhances	NULL
the	NULL
expression	NULL
of	NULL
many	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-4	NULL
,	NULL
but	NULL
not	NULL
others	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
.	NULL

Molecular	NULL
mechanisms	NULL
underlying	NULL
selective	NULL
expression	NULL
of	NULL
cytokines	NULL
by	NULL
T	NULL
cells	NULL
remain	NULL
poorly	NULL
understood	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
priming	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
selectively	NULL
enhances	NULL
IL-4	NULL
expression	NULL
relative	NULL
to	NULL
IL-2	NULL
expression	NULL
by	NULL
a	NULL
transcriptional	NULL
mechanism	NULL
involving	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
proteins	NULL
.	NULL

As	NULL
detected	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
,	NULL
priming	NULL
markedly	NULL
increases	NULL
the	NULL
activation-dependent	NULL
engagement	NULL
of	NULL
the	NULL
PO	NULL
and	NULL
P1	NULL
NFAT-binding	NULL
elements	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

Moreover	NULL
,	NULL
each	NULL
proximal	NULL
P	NULL
element	NULL
is	NULL
essential	NULL
for	NULL
optimal	NULL
IL-4	NULL
promoter	NULL
activity	NULL
.	NULL

Activated	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
contain	NULL
more	NULL
NFAT1	NULL
and	NULL
support	NULL
greater	NULL
NFAT-directed	NULL
transcription	NULL
than	NULL
unprimed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
while	NULL
activator	NULL
protein	NULL
1	NULL
binding	NULL
and	NULL
activator	NULL
protein	NULL
1-mediated	NULL
transcription	NULL
by	NULL
both	NULL
cell	NULL
types	NULL
is	NULL
similar	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
wild-type	NULL
NFAT1	NULL
substantially	NULL
increases	NULL
IL-4	NULL
promoter	NULL
activity	NULL
in	NULL
unprimed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
suggesting	NULL
NFAT1	NULL
may	NULL
be	NULL
limiting	NULL
for	NULL
IL-4	NULL
gene	NULL
expression	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
NFAT1	NULL
acts	NULL
as	NULL
a	NULL
dominant-negative	NULL
,	NULL
reducing	NULL
IL-4	NULL
promoter	NULL
activity	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
and	NULL
confirming	NULL
the	NULL
importance	NULL
of	NULL
endogenous	NULL
NFAT	NULL
to	NULL
increased	NULL
IL-4	NULL
gene	NULL
expression	NULL
by	NULL
effector	NULL
T	NULL
cells	NULL
.	NULL

NFAT1	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
major	NULL
NFAT	NULL
family	NULL
member	NULL
responsible	NULL
for	NULL
the	NULL
initial	NULL
increased	NULL
expression	NULL
of	NULL
IL-4	NULL
by	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

ytokine	NULL
secretion	NULL
by	NULL
T	NULL
cells	NULL
is	NULL
a	NULL
critical	NULL
component	NULL
of	NULL
Ag-specific	NULL
immunity	NULL
.	NULL

Among	NULL
the	NULL
many	NULL
cytokines	NULL
pro	NULL
duced	NULL
by	NULL
T	NULL
cells	NULL
,	NULL
IL-4	NULL
has	NULL
emerged	NULL
as	NULL
an	NULL
important	NULL
effector	NULL
molecule	NULL
(	NULL
1	NULL
)	NULL
.	NULL

IL-4-mediated	NULL
effects	NULL
include	NULL
the	NULL
enhancement	NULL
of	NULL
IgE	NULL
production	NULL
by	NULL
B	NULL
cells	NULL
and	NULL
the	NULL
differentiation	NULL
of	NULL
antigenically	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
into	NULL
a	NULL
Th2	NULL
population	NULL
rather	NULL
than	NULL
a	NULL
Th1	NULL
population	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Recent	NULL
in	NULL
vivo	NULL
experiments	NULL
in	NULL
which	NULL
IL-4	NULL
or	NULL
its	NULL
specific	NULL
receptor	NULL
has	NULL
been	NULL
manipulated	NULL
have	NULL
revealed	NULL
that	NULL
IL-4	NULL
is	NULL
essential	NULL
for	NULL
allergic	NULL
disease	NULL
and	NULL
is	NULL
a	NULL
critical	NULL
determinant	NULL
of	NULL
the	NULL
outcome	NULL
of	NULL
infection	NULL
or	NULL
autoimmunity	NULL
in	NULL
some	NULL
contexts	NULL
(	NULL
3	NULL
)	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
there	NULL
has	NULL
been	NULL
a	NULL
great	NULL
deal	NULL
of	NULL
interest	NULL
in	NULL
defining	NULL
the	NULL
mechanisms	NULL
controlling	NULL
IL-4	NULL
production	NULL
by	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
.	NULL

IL-4	NULL
production	NULL
and	NULL
mRNA	NULL
expression	NULL
by	NULL
T	NULL
cells	NULL
is	NULL
mainly	NULL
limited	NULL
to	NULL
CD4	NULL
T	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
activated	NULL
previously	NULL
in	NULL
vivo	NULL
.	NULL

These	NULL
include	NULL
recently	NULL
activated	NULL
effector	NULL
T	NULL
cells	NULL
,	NULL
most	NULL
of	NULL
which	NULL
are	NULL
short-lived	NULL
,	NULL
as	NULL
well	NULL
as	NULL
long-lived	NULL
memory	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
activation	NULL
may	NULL
have	NULL
occurred	NULL
months	NULL
or	NULL
years	NULL
before	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
IL-4	NULL
by	NULL
antigenically	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
is	NULL
minimal	NULL
,	NULL
while	NULL
bulk	NULL
populations	NULL
of	NULL
naive	NULL
,	NULL
effector	NULL
,	NULL
and	NULL
memory	NULL
CD4	NULL
T	NULL
cells	NULL
are	NULL
all	NULL
capable	NULL
of	NULL
substantial	NULL
IL-2	NULL
production	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

The	NULL
process	NULL
by	NULL
which	NULL
antigenically	NULL
naive	NULL
T	NULL
cells	NULL
are	NULL
converted	NULL
to	NULL
effector	NULL
T	NULL
cells	NULL
with	NULL
relatively	NULL
high	NULL
levels	NULL
of	NULL
IL-4	NULL
expression	NULL
can	NULL
*Departments	NULL
of	NULL
Pediatrics	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98195	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Oregon	NULL
Health	NULL
Sciences	NULL
University	NULL
,	NULL
Portland	NULL
,	NULL
OR	NULL
97201	NULL
Received	NULL
for	NULL
publication	NULL
October	NULL
6	NULL
,	NULL
1997	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
September	NULL
25	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grants	NULL
RO1	NULL
HD-36291	NULL
and	NULL
RO1	NULL
AI-26940	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
to	NULL
D.B.L	NULL
.	NULL
)	NULL

,	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
March	NULL
of	NULL
Dimes	NULL
(	NULL
to	NULL
D.B.L	NULL
.	NULL
)	NULL

,	NULL
and	NULL
by	NULL
National	NULL
Research	NULL
Service	NULL
Award	NULL
Grant	NULL
AIO7411	NULL
(	NULL
to	NULL
R.Q.C	NULL
.	NULL
)	NULL

.	NULL

R.Q.C	NULL
.	NULL

is	NULL
currently	NULL
funded	NULL
by	NULL
a	NULL
postdoctoral	NULL
research	NULL
fellowship	NULL
for	NULL
physicians	NULL
from	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
David	NULL
Lewis	NULL
,	NULL
Stanford	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Division	NULL
of	NULL
Immunology	NULL
and	NULL
Transplantation	NULL
Biology	NULL
,	NULL
300	NULL
Pasteur	NULL
Drive	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
94305-5208	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
dblewis	NULL
@	NULL
leland.stanford.edu	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
:	NULL
860-870.	NULL
be	NULL
mimicked	NULL
in	NULL
vitro	NULL
by	NULL
repetitive	NULL
activation	NULL
(	NULL
priming	NULL
)	NULL
of	NULL
freshly	NULL
isolated	NULL
(	NULL
fresh	NULL
)	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
exogenous	NULL
IL-2	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Priming	NULL
not	NULL
only	NULL
increases	NULL
IL-4	NULL
expression	NULL
but	NULL
that	NULL
of	NULL
most	NULL
other	NULL
T	NULL
cell-derived	NULL
cytokines	NULL
as	NULL
well	NULL
,	NULL
with	NULL
the	NULL
notable	NULL
exception	NULL
of	NULL
IL-2	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
priming	NULL
acts	NULL
to	NULL
modulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
and	NULL
other	NULL
cytokine	NULL
genes	NULL
remains	NULL
poorly	NULL
defined	NULL
.	NULL

Expression	NULL
of	NULL
IL-4	NULL
and	NULL
most	NULL
T	NULL
cell-derived	NULL
cytokines	NULL
appears	NULL
to	NULL
be	NULL
predominantly	NULL
regulated	NULL
by	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
transcription	NULL
(	NULL
7	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
transcription	NULL
mediated	NULL
by	NULL
the	NULL
5	NULL
'	NULL
flank	NULL
or	NULL
enhancer	NULL
region	NULL
of	NULL
cytokine	NULL
genes	NULL
,	NULL
including	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
,	NULL
granulocyte-macrophage	NULL
CSF	NULL
(	NULL
GM-CSF	NULL
)	NULL
``	NULL
,	NULL
IL-5	NULL
,	NULL
IL-13	NULL
,	NULL
and	NULL
CD4O-ligand	NULL
,	NULL
has	NULL
revealed	NULL
that	NULL
purine-rich	NULL
motifs	NULL
,	NULL
termed	NULL
P	NULL
elements	NULL
,	NULL
are	NULL
critical	NULL
for	NULL
lymphocyte	NULL
activation-induced	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
many	NULL
cases	NULL
,	NULL
the	NULL
P	NULL
element	NULL
in	NULL
conjunction	NULL
with	NULL
an	NULL
adjacent	NULL
binding	NULL
site	NULL
for	NULL
leucine	NULL
zipper	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
those	NULL
of	NULL
the	NULL
activator	NULL
protein	NULL
1	NULL
(	NULL
AP-1	NULL
)	NULL
family	NULL
,	NULL
binds	NULL
a	NULL
nuclear	NULL
protein	NULL
complex	NULL
,	NULL
termed	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
,	NULL
which	NULL
is	NULL
induced	NULL
by	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Recently	NULL
,	NULL
two	NULL
related	NULL
but	NULL
distinct	NULL
gene	NULL
products	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
,	NULL
NFAT1	NULL
(	NULL
NFATp	NULL
,	NULL
NFATc2	NULL
)	NULL
and	NULL
NFAT2	NULL
(	NULL
NFATc	NULL
,	NULL
NFATcl	NULL
)	NULL
,	NULL
have	NULL
been	NULL
cloned	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
their	NULL
binding	NULL
in	NULL
vitro	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
purine-rich	NULL
sequences	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
third	NULL
NFAT	NULL
gene	NULL
product	NULL
,	NULL
NFAT4	NULL
(	NULL
NFAT	NULL
'	NULL
x	NULL
,	NULL
NFATc3	NULL
)	NULL
,	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
by	NULL
thymocytes	NULL
,	NULL
has	NULL
been	NULL
cloned	NULL
based	NULL
on	NULL
sequence	NULL
homology	NULL
to	NULL
the	NULL
Rel	NULL
similarity	NULL
DNA	NULL
binding	NULL
region	NULL
(	NULL
14-17	NULL
)	NULL
.	NULL

Transient	NULL
overexpression	NULL
of	NULL
NFAT	NULL
proteins	NULL
in	NULL
Jurkat	NULL
thymoma	NULL
cells	NULL
increases	NULL
expression	NULL
of	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
TNF	NULL
promoter-driven	NULL
reporter	NULL
gene	NULL
constructs	NULL
,	NULL
indicating	NULL
that	NULL
NFAT	NULL
proteins	NULL
are	NULL
transcriptional	NULL
activators	NULL
of	NULL
cytokine	NULL
genes	NULL
(	NULL
14	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
,	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
,	NULL
inhibit	NULL
cytokine	NULL
gene	NULL
transcription	NULL
by	NULL
T	NULL
cells	NULL
,	NULL
including	NULL
IL-2	NULL
and	NULL
IL-4	NULL
,	NULL
by	NULL
blocking	NULL
the	NULL
calcineurin-dependent	NULL
dephosphorylation	NULL
of	NULL
NFAT	NULL
proteins	NULL
and	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
GM-CSF	NULL
,	NULL
granulocyte-macrophage	NULL
CSF	NULL
;	NULL
AP-1	NULL
,	NULL
activator	NULL
protein	NULL
1	NULL
;	NULL
NFAT	NULL
,	NULL
NF	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
FCF	NULL
,	NULL
flow	NULL
cytofluorometric	NULL
anal-ysis	NULL
;	NULL
CM	NULL
,	NULL
complete	NULL
medium	NULL
;	NULL
EF-1	NULL
@	NULL
,	NULL
elongation	NULL
factor-1a	NULL
;	NULL
PE	NULL
,	NULL
phycoerythrin	NULL
;	NULL
TSS	NULL
,	NULL
transcription	NULL
start	NULL
site	NULL
;	NULL
GEFP	NULL
,	NULL
green	NULL
fluorescent	NULL
protein	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
their	NULL
subsequent	NULL
shuttling	NULL
into	NULL
the	NULL
nucleus	NULL
(	NULL
12	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
NFAT	NULL
proteins	NULL
and	NULL
P	NULL
elements	NULL
in	NULL
regulating	NULL
IL-4	NULL
gene	NULL
transcription	NULL
during	NULL
the	NULL
extrathymic	NULL
differentiation	NULL
of	NULL
antigenically	NULL
naive	NULL
T	NULL
cells	NULL
into	NULL
effector	NULL
or	NULL
memory	NULL
T	NULL
cells	NULL
remains	NULL
to	NULL
be	NULL
defined	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
increased	NULL
IL-4	NULL
production	NULL
by	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
is	NULL
due	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
to	NULL
enhanced	NULL
transcription	NULL
directed	NULL
by	NULL
the	NULL
immediate	NULL
5	NULL
'	NULL
flank	NULL
promoter	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
.	NULL

We	NULL
further	NULL
show	NULL
that	NULL
both	NULL
proximal	NULL
P	NULL
elements	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
,	NULL
PO	NULL
and	NULL
P1	NULL
,	NULL
are	NULL
occupied	NULL
in	NULL
vivo	NULL
during	NULL
IL-4	NULL
transcription	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
both	NULL
are	NULL
independently	NULL
required	NULL
for	NULL
optimal	NULL
IL-4	NULL
reporter	NULL
gene	NULL
activity	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
.	NULL

An	NULL
analysis	NULL
of	NULL
nuclear	NULL
protein	NULL
complexes	NULL
formed	NULL
in	NULL
vitro	NULL
with	NULL
an	NULL
IL-4	NULL
P1	NULL
element	NULL
oligonucleotide	NULL
demonstrates	NULL
that	NULL
NFAT	NULL
1	NULL
is	NULL
the	NULL
major	NULL
NFAT	NULL
protein	NULL
forming	NULL
a	NULL
specific	NULL
complex	NULL
in	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
there	NULL
is	NULL
a	NULL
striking	NULL
and	NULL
direct	NULL
correlation	NULL
between	NULL
the	NULL
abundance	NULL
of	NULL
NFAT1	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
IL-4	NULL
gene	NULL
expression	NULL
.	NULL

Impor-tantly	NULL
,	NULL
expression	NULL
of	NULL
wild-type	NULL
and	NULL
truncated	NULL
NFAT1	NULL
constructs	NULL
demonstrates	NULL
that	NULL
NFAT1	NULL
is	NULL
a	NULL
limiting	NULL
component	NULL
for	NULL
IL-4	NULL
gene	NULL
transcription	NULL
by	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
and	NULL
also	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
enhanced	NULL
level	NULL
of	NULL
IL-4	NULL
gene	NULL
expression	NULL
by	NULL
primed	NULL
T	NULL
cells	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
and	NULL
IL-4	NULL
promoter-directed	NULL
reporter	NULL
gene	NULL
studies	NULL
involving	NULL
transient	NULL
overexpression	NULL
of	NULL
various	NULL
NFAT	NULL
family	NULL
members	NULL
both	NULL
indicate	NULL
that	NULL
NFAT1	NULL
,	NULL
rather	NULL
than	NULL
other	NULL
NFAT	NULL
family	NULL
members	NULL
,	NULL
contributes	NULL
to	NULL
increased	NULL
IL-4	NULL
gene	NULL
expression	NULL
by	NULL
primed	NULL
human	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
an	NULL
increase	NULL
in	NULL
NFAT1	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
is	NULL
an	NULL
important	NULL
mechanism	NULL
by	NULL
which	NULL
priming	NULL
of	NULL
T	NULL
cells	NULL
enhances	NULL
the	NULL
expression	NULL
of	NULL
IL-4	NULL
.	NULL

This	NULL
mechanism	NULL
,	NULL
or	NULL
a	NULL
similar	NULL
one	NULL
,	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
other	NULL
cytokines	NULL
by	NULL
primed	NULL
T	NULL
cells	NULL
,	NULL
a	NULL
critical	NULL
event	NULL
in	NULL
T	NULL
cell-mediated	NULL
immunity	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cells	NULL
and	NULL
priming	NULL
in	NULL
vitro	NULL
Whole	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
normal	NULL
adult	NULL
volunteer	NULL
donors	NULL
,	NULL
and	NULL
circulating	NULL
T	NULL
cells	NULL
or	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
obtained	NULL
by	NULL
treatment	NULL
of	NULL
whole	NULL
mononuclear	NULL
cells	NULL
with	NULL
T-cell	NULL
Lymphok-wik	NULL
or	NULL
T-Helper	NULL
Kwik	NULL
,	NULL
respectively	NULL
(	NULL
One	NULL
Lambda	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
as	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Flow	NULL
cytofluorometric	NULL
(	NULL
FCF	NULL
)	NULL
analysis	NULL
with	NULL
appropriate	NULL
directly	NULL
conjugated	NULL
mouse	NULL
anti-human	NULL
mAbs	NULL
revealed	NULL
that	NULL
the	NULL
isolated	NULL
CD4	NULL
T	NULL
cell	NULL
populations	NULL
were	NULL
routinely	NULL
>	NULL
98	NULL
%	NULL
CD3	NULL
*	NULL
,	NULL
<	NULL
1	NULL
%	NULL
CD8	NULL
*	NULL
,	NULL
and	NULL
85-98	NULL
%	NULL
CD4*	NULL
.	NULL

T	NULL
cells	NULL
or	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
1-2	NULL
X	NULL
10°/ml	NULL
)	NULL
were	NULL
primed	NULL
in	NULL
vitro	NULL
by	NULL
incubation	NULL
in	NULL
complete	NULL
medium	NULL
(	NULL
CM	NULL
;	NULL
Ref	NULL
.	NULL

20	NULL
)	NULL
containing	NULL
10	NULL
ng/ml	NULL
of	NULL
human	NULL
rIL-2	NULL
(	NULL
Proleukin-2	NULL
;	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WJ	NULL
)	NULL
,	NULL
3	NULL
ug/ml	NULL
of	NULL
Con	NULL
A	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
1	NULL
ng/ml	NULL
of	NULL
PMA	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
and	NULL
an	NULL
equal	NULL
number	NULL
of	NULL
irradiated	NULL
(	NULL
3300	NULL
rads	NULL
)	NULL
syngeneic	NULL
whole	NULL
mononuclear	NULL
cells	NULL
in	NULL
12-well	NULL
flat-bottom	NULL
plastic	NULL
tissue	NULL
culture	NULL
dishes	NULL
(	NULL
Corning	NULL
,	NULL
Corning	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Medium	NULL
was	NULL
replaced	NULL
every	NULL
2-3	NULL
days	NULL
with	NULL
fresh	NULL
CM	NULL
containing	NULL
IL-2	NULL
.	NULL

Primed	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
10-30	NULL
days	NULL
in	NULL
culture	NULL
,	NULL
and	NULL
viable	NULL
cells	NULL
were	NULL
obtained	NULL
by	NULL
centrifugation	NULL
over	NULL
a	NULL
Ficoll/Hypaque	NULL
gradient	NULL
before	NULL
experimentation	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
Primed	NULL
or	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
in	NULL
CM	NULL
with	NULL
1.5	NULL
uM	NULL
ionomycin	NULL
(	NULL
Calbiochem	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
50	NULL
ng/ml	NULL
of	NULL
PMA	NULL
for	NULL
5-6	NULL
h	NULL
,	NULL
under	NULL
conditions	NULL
previously	NULL
determined	NULL
to	NULL
be	NULL
optimal	NULL
for	NULL
maximal	NULL
IL-4	NULL
mRNA	NULL
accumulation	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Chom-czynski	NULL
and	NULL
Sacchi	NULL
(	NULL
21	NULL
)	NULL
using	NULL
a	NULL
commercial	NULL
kit	NULL
(	NULL
Trireagent	NULL
;	NULL
Molecular	NULL
Research	NULL
Center	NULL
,	NULL
Cincinnati	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

RNA	NULL
(	NULL
10	NULL
pug	NULL
per	NULL
sample	NULL
)	NULL
was	NULL
analyzed	NULL
for	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
elongation	NULL
factor-1a	NULL
(	NULL
EF-1	NULL
@	NULL
)	NULL
transcripts	NULL
by	NULL
RNA	NULL
blotting	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Intracellular	NULL
cytokine	NULL
detection	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
6	NULL
h	NULL
in	NULL
vitro	NULL
with	NULL
CM	NULL
containing	NULL
1.5	NULL
M	NULL
ionomcyin	NULL
,	NULL
50	NULL
ng/ml	NULL
of	NULL
PMA	NULL
,	NULL
and	NULL
2	NULL
M	NULL
monensin	NULL
(	NULL
Calbiochem	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
ice-cold	NULL
PBS	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
and	NULL
fixed	NULL
with	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
PBS	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Fixed	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
ice-cold	NULL
PBS	NULL
with	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
BSA	NULL
and	NULL
permeabilized	NULL
by	NULL
incubation	NULL
overnight	NULL
at	NULL
4°C	NULL
in	NULL
PBS-S	NULL
(	NULL
PBS	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
with	NULL
0.01	NULL
M	NULL
HEPES	NULL
,	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
BSA	NULL
,	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
saponin	NULL
(	NULL
Fluka	NULL
,	NULL
861	NULL
Ronkonkoma	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
and	NULL
10	NULL
%	NULL
human	NULL
type	NULL
AB	NULL
serum	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
-conjugated	NULL
8D4-8	NULL
mAb	NULL
(	NULL
murine	NULL
IgG1	NULL
anit-human	NULL
IL-4	NULL
;	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
PE-conjugated	NULL
MQ1-17H12	NULL
(	NULL
murine	NULL
IgG2a	NULL
anti-human	NULL
IL-2	NULL
;	NULL
PharMin-gen	NULL
)	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

FITC-conjugated	NULL
murine	NULL
IgG2a	NULL
anti-human	NULL
CD3	NULL
mAb	NULL
(	NULL
$	NULL
4.1	NULL
;	NULL
Caltag	NULL
Laboratories	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
a	NULL
FITC-conjugated	NULL
IgG2a	NULL
mAb	NULL
control	NULL
(	NULL
Caltag	NULL
Laboratories	NULL
)	NULL
were	NULL
included	NULL
with	NULL
the	NULL
anti-cytokine	NULL
mAbs	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
sequentially	NULL
washed	NULL
with	NULL
PBS-S	NULL
and	NULL
PBS	NULL
alone	NULL
before	NULL
analysis	NULL
on	NULL
a	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Preincubation	NULL
of	NULL
anti-IL-4	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
human	NULL
rIL-4	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
Ken	NULL
Grabstein	NULL
,	NULL
Immunex	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
or	NULL
anti-IL-2	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
human	NULL
rIL-2	NULL
(	NULL
Proleukin-2	NULL
)	NULL
for	NULL
1	NULL
h	NULL
on	NULL
ice	NULL
before	NULL
addition	NULL
to	NULL
the	NULL
cells	NULL
resulted	NULL
in	NULL
>	NULL
95	NULL
%	NULL
and	NULL
>	NULL
70	NULL
%	NULL
inhibition	NULL
of	NULL
staining	NULL
,	NULL
respectively	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Debris	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
analysis	NULL
by	NULL
gating	NULL
,	NULL
using	NULL
side-scatter	NULL
vs	NULL
forward-scatter	NULL
plots	NULL
.	NULL

FCF	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
Lysys	NULL
II	NULL
software	NULL
program	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
and	NULL
plotted	NULL
with	NULL
the	NULL
program	NULL
Reproman	NULL
(	NULL
True	NULL
Facts	NULL
Software	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

Dimethyl	NULL
sulfate	NULL
in	NULL
vivo	NULL
footprinting	NULL
In	NULL
vivo	NULL
footprinting	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Primed	NULL
or	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
CM	NULL
,	NULL
or	NULL
CM	NULL
with	NULL
1.5	NULL
M	NULL
ionomycin	NULL
,	NULL
and	NULL
50	NULL
ng/ml	NULL
of	NULL
PMA	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
centrifuged	NULL
and	NULL
resuspended	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
CM	NULL
at	NULL
23°C	NULL
,	NULL
and	NULL
2.5	NULL
pil	NULL
of	NULL
dimethyl	NULL
sulfate	NULL
(	NULL
Aldrich	NULL
,	NULL
Milwaukee	NULL
,	NULL
WI	NULL
)	NULL
was	NULL
added	NULL
to	NULL
methylate	NULL
the	NULL
N-7	NULL
position	NULL
of	NULL
G	NULL
residues	NULL
and	NULL
the	NULL
N-3	NULL
position	NULL
of	NULL
A	NULL
residues	NULL
.	NULL

After	NULL
gentle	NULL
mixing	NULL
for	NULL
30	NULL
s	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
immediately	NULL
transferred	NULL
to	NULL
15	NULL
ml	NULL
of	NULL
ice-cold	NULL
PBS	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
with	NULL
2	NULL
ml	NULL
of	NULL
2-ME	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
ice-cold	NULL
PBS	NULL
and	NULL
resuspended	NULL
and	NULL
lysed	NULL
in	NULL
SDS	NULL
as	NULL
described	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Genomic	NULL
DNA	NULL
was	NULL
isolated	NULL
from	NULL
the	NULL
cell	NULL
lysate	NULL
by	NULL
digestion	NULL
with	NULL
1	NULL
mg/ml	NULL
of	NULL
proteinase	NULL
K	NULL
(	NULL
Life	NULL
Tech-nologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
followed	NULL
by	NULL
repeated	NULL
phenol/	NULL
chloroform	NULL
extraction	NULL
and	NULL
precipitation	NULL
with	NULL
sodium	NULL
acetate	NULL
and	NULL
ethanol	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
dissolved	NULL
in	NULL
0.017	NULL
M	NULL
HCI	NULL
and	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
to	NULL
open	NULL
the	NULL
ring	NULL
structure	NULL
of	NULL
the	NULL
methylated	NULL
bases	NULL
.	NULL

Strand	NULL
cleavage	NULL
was	NULL
effected	NULL
at	NULL
each	NULL
methylated	NULL
base	NULL
by	NULL
piperidine	NULL
(	NULL
Aldrich	NULL
)	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
cleaved	NULL
DNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
substrate	NULL
for	NULL
ligation-mediated	NULL
PCR	NULL
amplification	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
nested	NULL
primers	NULL
used	NULL
to	NULL
visualize	NULL
the	NULL
noncoding	NULL
strand	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
proximal	NULL
promoter	NULL
were	NULL
primer	NULL
315	NULL
(	NULL
5-AAGGTTTCATTITTC	NULL
CTATTGGTC	NULL
)	NULL
,	NULL
primer	NULL
316	NULL
(	NULL
5-GGTCTGATTTCACAGGAACATTIT	NULL
TACCTG	NULL
,	NULL
and	NULL
primer	NULL
317	NULL
(	NULL
5-GGTCTGATITCACAGGAACATTT	NULL
TACCTGTTTGTGAG	NULL
)	NULL
.	NULL

Primers	NULL
315	NULL
,	NULL
316	NULL
,	NULL
and	NULL
317	NULL
were	NULL
annealed	NULL
in	NULL
3	NULL
mM	NULL
MgCl	NULL
,	NULL
at	NULL
54°C	NULL
,	NULL
57°C	NULL
,	NULL
and	NULL
62°C	NULL
,	NULL
respectively	NULL
.	NULL

Primer	NULL
317	NULL
was	NULL
*°P-labeled	NULL
,	NULL
and	NULL
the	NULL
footprints	NULL
were	NULL
detected	NULL
by	NULL
analysis	NULL
on	NULL
sequencing	NULL
gels	NULL
using	NULL
autoradiography	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
dimethyl	NULL
sulfate	NULL
modification	NULL
of	NULL
genomic	NULL
DNA	NULL
was	NULL
conducted	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Reporter	NULL
gene	NULL
and	NULL
NFAT	NULL
expression	NULL
constructs	NULL
pIL-4-Luc	NULL
was	NULL
created	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
promoter	NULL
(	NULL
-745	NULL
to	NULL
+60	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
TSS	NULL
)	NULL
)	NULL
using	NULL
standard	NULL
methods	NULL
(	NULL
27	NULL
)	NULL
and	NULL
the	NULL
human	NULL
IL-4	NULL
genomic	NULL
clone	NULL
,	NULL
10.2	NULL
,	NULL
as	NULL
a	NULL
template	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
primers	NULL
included	NULL
Psf	NULL
and	NULL
HindIII	NULL
sites	NULL
in	NULL
their	NULL
5	NULL
'	NULL
region	NULL
to	NULL
facilitate	NULL
subcloning	NULL
into	NULL
the	NULL
polylinker	NULL
of	NULL
the	NULL
promoterless	NULL
pGL2-Basic	NULL
luciferase	NULL
reporter	NULL
gene	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

pIL-2-Luc	NULL
was	NULL
made	NULL
by	NULL
subcloning	NULL
the	NULL
human	NULL
HindIIW/HindlII	NULL
IL-2	NULL
promoter	NULL
segment	NULL
(	NULL
-568	NULL
to	NULL
+50	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
TSS	NULL
)	NULL
(	NULL
28	NULL
)	NULL
into	NULL
pGL2-Basic	NULL
.	NULL

pCMV-Luc	NULL
,	NULL
provided	NULL
by	NULL
Dr.	NULL
Marianne	NULL
Sweetser	NULL
(	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
,	NULL
was	NULL
created	NULL
by	NULL
inserting	NULL
a	NULL
1150-bp	NULL
Smal/HindIII-digested	NULL
fragment	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
immediate-early	NULL
CMV	NULL
gene	NULL
(	NULL
29	NULL
)	NULL
into	NULL
pGL2-Basic	NULL
.	NULL

The	NULL
pAP-1-Luc	NULL
and	NULL
pNFAT-Luc	NULL
multimer-driven	NULL
luciferase	NULL
constructs	NULL
(	NULL
30	NULL
)	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Charles	NULL
Zacharchuk	NULL
(	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

NFAT1I/	NULL
pREP-4	NULL
,	NULL
containing	NULL
a	NULL
full-length	NULL
human	NULL
NFATp	NULL
cDNA	NULL
segment	NULL
driven	NULL
by	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
promoter	NULL
(	NULL
14	NULL
)	NULL
,	NULL
and	NULL
a	NULL
similar	NULL
construct	NULL
,	NULL
NFAT4/	NULL
pREP-4	NULL
,	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Timothy	NULL
Hoey	NULL
(	NULL
Tularik	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

NFAT2/pREP-4	NULL
was	NULL
generated	NULL
by	NULL
subcloning	NULL
a	NULL
2.8-kb	NULL
Xho	NULL
BamHI	NULL
fragment	NULL
containing	NULL
a	NULL
full-length	NULL
human	NULL
NFATc	NULL
cDNA	NULL
segment	NULL
(	NULL
13	NULL
)	NULL
(	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Gerald	NULL
Crabtree	NULL
,	NULL
Stanford	NULL
University	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
immediately	NULL
downstream	NULL
of	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
promoter	NULL
in	NULL
the	NULL
pREP-4	NULL
expression	NULL
vector	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

A	NULL
dominant-negative	NULL
NFAT	NULL
expression	NULL
vector	NULL
,	NULL
NFATIANH	NULL
,	NULL
/pREP-4	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
amino	NULL
terminal	NULL
transcriptional	NULL
activation	NULL
domain	NULL
,	NULL
was	NULL
created	NULL
by	NULL
subcloning	NULL
a	NULL
5.7-kb	NULL
Xhol/KpnI	NULL
truncated	NULL
fragment	NULL
of	NULL
the	NULL
full-length	NULL
NFAT1-coding	NULL
sequence	NULL
into	NULL
the	NULL
pREP-4	NULL
expression	NULL
vector	NULL
.	NULL

Multiple	NULL
independent	NULL
preparations	NULL
of	NULL
plasmids	NULL
used	NULL
for	NULL
transfection	NULL
were	NULL
isolated	NULL
by	NULL
banding	NULL
in	NULL
cesium	NULL
chloride	NULL
(	NULL
24	NULL
)	NULL
or	NULL
by	NULL
using	NULL
a	NULL
commercial	NULL
affinity	NULL
column	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Qia-gen	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
862	NULL
Site-directed	NULL
mutagenesis	NULL
Mutant	NULL
luciferase	NULL
constructs	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
promoter	NULL
,	NULL
POm-Luc	NULL
and	NULL
P1m-Luc	NULL
,	NULL
were	NULL
generated	NULL
by	NULL
a	NULL
standard	NULL
protocol	NULL
for	NULL
single-stranded	NULL
DNA	NULL
site-directed	NULL
mutagenesis	NULL
,	NULL
using	NULL
Escherichia	NULL
coli	NULL
C1236	NULL
,	NULL
M13KO7	NULL
helper	NULL
phage	NULL
,	NULL
and	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
human	NULL
IL-4	NULL
PO	NULL
site	NULL
(	NULL
5	NULL
'	NULL
end	NULL
beginning	NULL
at	NULL
-58	NULL
)	NULL
was	NULL
mutated	NULL
from	NULL
ATTT	NULL
TCCCT	NULL
to	NULL
ATTTGAGCT	NULL
,	NULL
and	NULL
the	NULL
human	NULL
IL-4	NULL
P1	NULL
site	NULL
(	NULL
5	NULL
'	NULL
end	NULL
beginning	NULL
at	NULL
-76	NULL
)	NULL
was	NULL
changed	NULL
from	NULL
AATTTCCAA	NULL
to	NULL
AATTCGAAA	NULL
.	NULL

Mutant	NULL
plasmid	NULL
constructs	NULL
were	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
and	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
,	NULL
since	NULL
the	NULL
designed	NULL
mutations	NULL
created	NULL
new	NULL
unique	NULL
restriction	NULL
sites	NULL
.	NULL

Transient	NULL
transfections	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
plasmid	NULL
DNA	NULL
using	NULL
a	NULL
modified	NULL
protocol	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
freshly	NULL
isolated	NULL
or	NULL
in	NULL
vitro-primed	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
electroporated	NULL
with	NULL
10	NULL
pug	NULL
of	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
27	NULL
,	NULL
32	NULL
)	NULL
.	NULL

For	NULL
cotransfections	NULL
,	NULL
5-20	NULL
ug	NULL
of	NULL
pREP-4-based	NULL
expression	NULL
plasmids	NULL
was	NULL
included	NULL
in	NULL
the	NULL
electroporation	NULL
.	NULL

All	NULL
time	NULL
constants	NULL
generated	NULL
during	NULL
electroporations	NULL
were	NULL
within	NULL
10	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
time	NULL
constant	NULL
for	NULL
any	NULL
particular	NULL
experiment	NULL
.	NULL

Cell	NULL
viability	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
at	NULL
1	NULL
h	NULL
postelectroporation	NULL
,	NULL
was	NULL
>	NULL
80	NULL
%	NULL
for	NULL
each	NULL
individual	NULL
transfection	NULL
.	NULL

One	NULL
million	NULL
live	NULL
cells	NULL
per	NULL
well	NULL
were	NULL
stimulated	NULL
and	NULL
analyzed	NULL
for	NULL
luciferase	NULL
activity	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Statistical	NULL
analyses	NULL
,	NULL
including	NULL
Student	NULL
's	NULL
f	NULL
tests	NULL
for	NULL
two	NULL
group	NULL
comparisons	NULL
,	NULL
were	NULL
performed	NULL
using	NULL
Sigma	NULL
Stat	NULL
2.0	NULL
software	NULL
(	NULL
Jandel	NULL
Scientific	NULL
,	NULL
San	NULL
Rafael	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
transfection	NULL
efficiency	NULL
was	NULL
analyzed	NULL
by	NULL
FCF	NULL
using	NULL
a	NULL
plasmid	NULL
,	NULL
pGreen	NULL
Lantern-1	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
,	NULL
encoding	NULL
green	NULL
fluorescent	NULL
protein	NULL
(	NULL
GFP	NULL
)	NULL
from	NULL
Aeguorea	NULL
victoria	NULL
jellyfish	NULL
(	NULL
34	NULL
)	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
intact	NULL
immediate-early	NULL
CMV	NULL
promoter	NULL
.	NULL

Primed	NULL
and	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
electroporated	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
pGreen	NULL
Lantern-1	NULL
or	NULL
pEQ-176	NULL
(	NULL
LacZ	NULL
driven	NULL
by	NULL
the	NULL
immediate-early	NULL
CMV	NULL
promoter	NULL
,	NULL
as	NULL
a	NULL
control	NULL
)	NULL
,	NULL
and	NULL
cultured	NULL
in	NULL
CM	NULL
for	NULL
5	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
with	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
BSA	NULL
,	NULL
incubated	NULL
with	NULL
PE-conjugated	NULL
anti-CD4	NULL
(	NULL
IgG2a	NULL
,	NULL
clone	NULL
$	NULL
3.5	NULL
;	NULL
Caltag	NULL
Laboratories	NULL
)	NULL
or	NULL
a	NULL
PE-conjugated	NULL
IgG2a	NULL
control	NULL
mAb	NULL
(	NULL
Caltag	NULL
Laboratories	NULL
)	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
then	NULL
washed	NULL
sequentially	NULL
in	NULL
PBS	NULL
with	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
BSA	NULL
,	NULL
and	NULL
in	NULL
PBS	NULL
before	NULL
analysis	NULL
by	NULL
FACScan	NULL
.	NULL

GFP	NULL
was	NULL
detected	NULL
using	NULL
FITC	NULL
filters	NULL
(	NULL
475-nm	NULL
excitation	NULL
peak	NULL
,	NULL
485-nm	NULL
barrier	NULL
peak	NULL
,	NULL
490-nm	NULL
emission	NULL
peak	NULL
)	NULL
as	NULL
described	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Nuclear	NULL
protein	NULL
preparations	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
Fresh	NULL
and	NULL
primed	NULL
whole	NULL
T	NULL
cell	NULL
and	NULL
CD4	NULL
T	NULL
cell	NULL
populations	NULL
were	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
Con	NULL
A	NULL
(	NULL
25	NULL
pug/m1	NULL
)	NULL
,	NULL
or	NULL
ionomycin	NULL
(	NULL
1.5	NULL
M	NULL
)	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
and	NULL
PMA	NULL
(	NULL
25	NULL
ng/ml	NULL
)	NULL
,	NULL
and	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
as	NULL
described	NULL
(	NULL
36	NULL
)	NULL
.	NULL

All	NULL
nuclear	NULL
preparations	NULL
analyzed	NULL
were	NULL
free	NULL
of	NULL
significant	NULL
contamination	NULL
by	NULL
cytoplasmic	NULL
protein	NULL
based	NULL
on	NULL
the	NULL
lack	NULL
of	NULL
detectable	NULL
signal	NULL
for	NULL
lactate	NULL
dehydrogenase	NULL
protein	NULL
by	NULL
chemiluminescent	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
NFAT	NULL
!	NULL

-specific	NULL
antiserum	NULL
and	NULL
peptide	NULL
,	NULL
67.1	NULL
,	NULL
against	NULL
which	NULL
it	NULL
was	NULL
made	NULL
(	NULL
37	NULL
)	NULL
,	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Anjana	NULL
Rao	NULL
(	NULL
Dana-Farber	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

This	NULL
antiserum	NULL
recognizes	NULL
the	NULL
amino-terminal	NULL
portion	NULL
of	NULL
NFAT1	NULL
(	NULL
AISSPSGLAYPDDVLDYGL	NULL
)	NULL
that	NULL
is	NULL
not	NULL
conserved	NULL
in	NULL
NFAT2	NULL
(	NULL
37	NULL
)	NULL
or	NULL
NFAT4	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Double-stranded	NULL
oligonucleotides	NULL
used	NULL
as	NULL
P-labeled	NULL
probes	NULL
or	NULL
as	NULL
unlabeled	NULL
competitors	NULL
were	NULL
synthesized	NULL
using	NULL
an	NULL
Oligo	NULL
1000	NULL
DNA	NULL
Synthesizer	NULL
(	NULL
Beckman	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
oligonucleotides	NULL
(	NULL
the	NULL
sequence	NULL
of	NULL
only	NULL
one	NULL
strand	NULL
is	NULL
shown	NULL
)	NULL
included	NULL
the	NULL
human	NULL
IL-4	NULL
promoter	NULL
P1	NULL
element	NULL
(	NULL
-66	NULL
to	NULL
-82	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
TSS	NULL
)	NULL
,	NULL
5'-ATTGGAAATTITTTCGTTA	NULL
(	NULL
noncoding	NULL
strand	NULL
)	NULL
(	NULL
39	NULL
)	NULL
;	NULL
and	NULL
a	NULL
human	NULL
me-tallothionein	NULL
promoter	NULL
AP-1-binding	NULL
site	NULL
,	NULL
5'-ACGTGACTCAGCGCGC	NULL
(	NULL
coding	NULL
strand	NULL
)	NULL
(	NULL
40	NULL
)	NULL
.	NULL

A	NULL
mutant	NULL
human	NULL
IL-4	NULL
P1	NULL
oligonucleotide	NULL
(	NULL
5-ATT	NULL
GGTCATTTTCGTTA	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
nonspecific	NULL
competitor	NULL
,	NULL
with	NULL
the	NULL
mutated	NULL
residues	NULL
indicated	NULL
in	NULL
bold	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
Total	NULL
cell	NULL
protein	NULL
preparations	NULL
from	NULL
freshly	NULL
isolated	NULL
or	NULL
in	NULL
vitro-primed	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
41	NULL
)	NULL
.	NULL

One	NULL
hundred	NULL
million	NULL
cells	NULL
per	NULL
group	NULL
were	NULL
washed	NULL
in	NULL
ice-cold	NULL
PBS	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
Tris-EDTA-NaCl	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
M	NULL
dichloroisocoumarin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
0.5	NULL
ng/ml	NULL
of	NULL
leupeptin	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
,	NULL
0.5	NULL
ng/m	NULL
!	NULL

of	NULL
pepstatin	NULL
A	NULL
(	NULL
Calbiochem	NULL
)	NULL
,	NULL
0.5	NULL
ng/ml	NULL
of	NULL
aprotinin	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
,	NULL
10	NULL
M	NULL
chymostatin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
0.5	NULL
uM	NULL
pefabloc	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanidate	NULL
)	NULL
for	NULL
5	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Cellular	NULL
debris	NULL
was	NULL
centrifuged	NULL
for	NULL
5	NULL
min	NULL
at	NULL
7,500	NULL
X	NULL
g	NULL
,	NULL
and	NULL
supernatants	NULL
containing	NULL
total	NULL
cellular	NULL
proteins	NULL
were	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
analyzed	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
for	NULL
an	NULL
aliquot	NULL
of	NULL
each	NULL
protein	NULL
preparation	NULL
by	NULL
the	NULL
Bradford	NULL
assay	NULL
using	NULL
a	NULL
com	NULL
NFAT	NULL
ENHANCES	NULL
IL-4	NULL
IN	NULL
PRIMED	NULL
CD4	NULL
T	NULL
CELLS	NULL
mercially	NULL
available	NULL
kit	NULL
(	NULL
Pierce	NULL
Chemical	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Total	NULL
or	NULL
nuclear	NULL
protein	NULL
(	NULL
20	NULL
pug/sample	NULL
)	NULL
was	NULL
loaded	NULL
per	NULL
lane	NULL
in	NULL
SDS-containing	NULL
loading	NULL
buffer	NULL
onto	NULL
a	NULL
vertical	NULL
SDS-PAGE	NULL
gel	NULL
with	NULL
a	NULL
4.6	NULL
%	NULL
acrylamide	NULL
stacking	NULL
gel	NULL
and	NULL
a	NULL
10	NULL
%	NULL
acrylamide	NULL
separating	NULL
gel	NULL
,	NULL
and	NULL
electrophoresed	NULL
for	NULL
16	NULL
h	NULL
at	NULL
50	NULL
V/h	NULL
in	NULL
SDS-containing	NULL
running	NULL
buffer	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
then	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
by	NULL
electroblotting	NULL
at	NULL
50	NULL
V/h	NULL
for	NULL
12	NULL
h.	NULL
The	NULL
blot	NULL
was	NULL
blocked	NULL
for	NULL
1	NULL
h	NULL
with	NULL
PBS	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
and	NULL
0.1	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Tween	NULL
20	NULL
(	NULL
PBS-Tween	NULL
)	NULL
,	NULL
containing	NULL
3	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
BSA	NULL
,	NULL
and	NULL
then	NULL
immu-nohybridized	NULL
for	NULL
2	NULL
h	NULL
with	NULL
anti-NFAT1-specific	NULL
rabbit	NULL
antiserum	NULL
,	NULL
67.1	NULL
,	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1:2000	NULL
in	NULL
PBS-Tween	NULL
.	NULL

After	NULL
three	NULL
consecutive	NULL
washes	NULL
in	NULL
PBS-Tween	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
reacted	NULL
for	NULL
2	NULL
h	NULL
with	NULL
a	NULL
1:2000	NULL
dilution	NULL
of	NULL
donkey	NULL
anti-rabbit	NULL
Ig-horseradish	NULL
peroxidase	NULL
(	NULL
Amersham	NULL
)	NULL
in	NULL
PBS-Tween	NULL
,	NULL
followed	NULL
by	NULL
three	NULL
washes	NULL
with	NULL
PBS-Tween	NULL
.	NULL

In	NULL
the	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
nuclear	NULL
protein	NULL
(	NULL
15	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
from	NULL
freshly	NULL
isolated	NULL
or	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
was	NULL
analyzed	NULL
using	NULL
4-15	NULL
%	NULL
polyacrylamide	NULL
precast	NULL
gels	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
NFAT1	NULL
was	NULL
detected	NULL
with	NULL
a	NULL
1:500	NULL
dilution	NULL
of	NULL
a	NULL
commercially	NULL
available	NULL
NFAT	NULL
mouse	NULL
mAb	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
,	NULL
NFAT2	NULL
with	NULL
a	NULL
1:2500	NULL
dilution	NULL
of	NULL
a	NULL
NFAT2-specific	NULL
mouse	NULL
mAb	NULL
,	NULL
7A6	NULL
(	NULL
42	NULL
)	NULL
,	NULL
generously	NULL
provided	NULL
by	NULL
Drs	NULL
.	NULL

Luika	NULL
Timmerman	NULL
and	NULL
Gerald	NULL
Crabtree	NULL
(	NULL
Stanford	NULL
University	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
NFAT4	NULL
with	NULL
a	NULL
1:1,000	NULL
dilution	NULL
of	NULL
an	NULL
anti-NFAT4-specific	NULL
rabbit	NULL
antiserum	NULL
,	NULL
provided	NULL
by	NULL
the	NULL
same	NULL
investigators	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Mouse	NULL
mAb	NULL
were	NULL
detected	NULL
with	NULL
1:500	NULL
dilutions	NULL
goat	NULL
anti-mouse	NULL
alkaline	NULL
phosphatase-conjugated	NULL
Abs	NULL
,	NULL
and	NULL
the	NULL
rabbit	NULL
antisera	NULL
was	NULL
detected	NULL
with	NULL
a	NULL
1:500	NULL
dilution	NULL
of	NULL
goat	NULL
anti-rabbit	NULL
alkaline	NULL
phosphatase-conjugated	NULL
antisera	NULL
,	NULL
as	NULL
per	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
determined	NULL
to	NULL
be	NULL
free	NULL
of	NULL
cytosolic	NULL
contamination	NULL
,	NULL
as	NULL
c-Rel	NULL
was	NULL
only	NULL
detected	NULL
after	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Multicolored	NULL
m.w	NULL
.	NULL

protein	NULL
standards	NULL
(	NULL
Novex	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
;	NULL
or	NULL
Amersham	NULL
)	NULL
were	NULL
run	NULL
in	NULL
parallel	NULL
for	NULL
comparison	NULL
.	NULL

Results	NULL
Primed	NULL
CD4	NULL
T	NULL
cells	NULL
have	NULL
greater	NULL
expression	NULL
of	NULL
IL-4	NULL
transcripts	NULL
and	NULL
more	NULL
IL-4	NULL
protein	NULL
per	NULL
cell	NULL
than	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
Our	NULL
previous	NULL
in	NULL
situ	NULL
hybridization	NULL
experiments	NULL
using	NULL
polyclonally	NULL
activated	NULL
adult	NULL
human	NULL
CD4	NULL
T	NULL
cells	NULL
have	NULL
shown	NULL
a	NULL
markedly	NULL
lower	NULL
frequency	NULL
of	NULL
cells	NULL
expressing	NULL
IL-4	NULL
mRNA	NULL
than	NULL
IL-2	NULL
transcripts	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
bulk	NULL
of	NULL
these	NULL
IL-4-producing	NULL
CD4	NULL
T	NULL
cells	NULL
express	NULL
a	NULL
CD4SRO®	NULL
``	NULL
®	NULL
``	NULL
CD45RA'**	NULL
memory/effector	NULL
cell	NULL
surface	NULL
phenotype	NULL
(	NULL
7	NULL
,	NULL
43	NULL
)	NULL
,	NULL
while	NULL
IL-2	NULL
is	NULL
produced	NULL
at	NULL
a	NULL
similar	NULL
frequency	NULL
by	NULL
memory/	NULL
effector	NULL
and	NULL
antigenically	NULL
naive	NULL
(	NULL
CD45RO°*CD45RA	NULL
``	NULL
®	NULL
``	NULL
)	NULL
cells	NULL
.	NULL

Since	NULL
freshly	NULL
isolated	NULL
T	NULL
cells	NULL
activated	NULL
and	NULL
cultured	NULL
in	NULL
vitro	NULL
for	NULL
several	NULL
days	NULL
to	NULL
weeks	NULL
(	NULL
primed	NULL
)	NULL
1	NULL
)	NULL
have	NULL
an	NULL
increased	NULL
ability	NULL
to	NULL
produce	NULL
most	NULL
T	NULL
cell-derived	NULL
cytokines	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
IL-2	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
,	NULL
and	NULL
2	NULL
)	NULL
tend	NULL
to	NULL
lose	NULL
expression	NULL
of	NULL
CD4SRA	NULL
and	NULL
gain	NULL
expression	NULL
of	NULL
CD45RO	NULL
(	NULL
44	NULL
)	NULL
,	NULL
priming	NULL
appears	NULL
to	NULL
mimic	NULL
the	NULL
process	NULL
by	NULL
which	NULL
T	NULL
cells	NULL
in	NULL
vivo	NULL
acquire	NULL
an	NULL
enhanced	NULL
ability	NULL
to	NULL
produce	NULL
cytokines	NULL
during	NULL
their	NULL
differentiation	NULL
from	NULL
antigenically	NULL
naive	NULL
to	NULL
memory/effector	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
these	NULL
earlier	NULL
results	NULL
,	NULL
we	NULL
found	NULL
here	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
mRNA	NULL
for	NULL
IL-4	NULL
relative	NULL
to	NULL
that	NULL
for	NULL
EF-1	NULL
«	NULL
@	NULL
,	NULL
a	NULL
constitu-tively	NULL
expressed	NULL
housekeeping	NULL
gene	NULL
(	NULL
7	NULL
,	NULL
20	NULL
)	NULL
,	NULL
was	NULL
substantially	NULL
higher	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
than	NULL
freshly	NULL
isolated	NULL
circulating	NULL
CD4	NULL
T	NULL
cells	NULL
after	NULL
polyclonal	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

The	NULL
small	NULL
amount	NULL
of	NULL
IL-4	NULL
transcripts	NULL
detected	NULL
in	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
is	NULL
most	NULL
likely	NULL
produced	NULL
by	NULL
a	NULL
subset	NULL
of	NULL
circulating	NULL
memory	NULL
CD4SRO®*®	NULL
``	NULL
CD45RA	NULL
!	NULL

°~	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
produced	NULL
either	NULL
more	NULL
or	NULL
equivalent	NULL
amounts	NULL
of	NULL
IL-2	NULL
mRNA	NULL
,	NULL
relative	NULL
to	NULL
EF-l	NULL
«	NULL
transcripts	NULL
,	NULL
compared	NULL
with	NULL
primed/effector	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Primed	NULL
CD4	NULL
T	NULL
cells	NULL
always	NULL
produced	NULL
more	NULL
IL-4	NULL
on	NULL
a	NULL
per	NULL
cell	NULL
basis	NULL
than	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
although	NULL
there	NULL
was	NULL
substantial	NULL
variability	NULL
among	NULL
donors	NULL
for	NULL
IL-4	NULL
production	NULL
by	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Results	NULL
of	NULL
an	NULL
experiment	NULL
,	NULL
in	NULL
which	NULL
IL-4	NULL
production	NULL
was	NULL
analyzed	NULL
in	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
by	NULL
intracellular	NULL
cytokine	NULL
staining	NULL
,	NULL
and	NULL
where	NULL
the	NULL
donor	NULL
source	NULL
of	NULL
the	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
was	NULL
iden-tical	NULL
,	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

After	NULL
a	NULL
6-h	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
,	NULL
38	NULL
%	NULL
of	NULL
the	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
accumulated	NULL
IL-4	NULL
protein	NULL
,	NULL
while	NULL
only	NULL
13	NULL
%	NULL
(	NULL
typically	NULL
only	NULL
2-5	NULL
%	NULL
for	NULL
most	NULL
donors	NULL
)	NULL
of	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
had	NULL
detectable	NULL
IL-4	NULL
.	NULL

Furthermore	NULL
,	NULL
relatively	NULL
high	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
863	NULL
A	NULL
.	NULL

B	NULL
.	NULL

FIGURE	NULL
1	NULL
.	NULL

-	NULL
Primed/effector	NULL
CD4	NULL
T	NULL
cells	NULL
accumu-	NULL
Freshly-	NULL
Freshly-Isolated	NULL
Primed	NULL
late	NULL
more	NULL
IL-4	NULL
mRNA	NULL
and	NULL
protein	NULL
than	NULL
freshly	NULL
iso-	NULL
isolated	NULL
Primed	NULL
CD4	NULL
T	NULL
Cells	NULL
CD4	NULL
T	NULL
Cells	NULL
lated	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
10	NULL
ug	NULL
£	NULL
fo	NULL
f	NULL
A	NULL
F	NULL
]	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
be-	NULL
Activation	NULL
:	NULL
_	NULL
fore	NULL
(	NULL
-	NULL
)	NULL
and	NULL
5	NULL
h	NULL
after	NULL
(	NULL
+	NULL
)	NULL
treatment	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
probed	NULL
for	NULL
IL-4	NULL
and	NULL
IL-2	NULL
,	NULL
IL-4	NULL
and	NULL
,	NULL
to	NULL
control	NULL
for	NULL
equivalence	NULL
of	NULL
loading	NULL
,	NULL
with	NULL
EF-	NULL
1a	NULL
.	NULL

B	NULL
,	NULL
Intracellular	NULL
cytokine	NULL
staining	NULL
of	NULL
saponin-per-	NULL
meabilized	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
after	NULL
6	NULL
h	NULL
of	NULL
IL-2	NULL
stimulation	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

Cell	NULL
surface	NULL
staining	NULL
for	NULL
CD3e	NULL
is	NULL
depicted	NULL
along	NULL
the	NULL
x-axis	NULL
,	NULL
with	NULL
cytokine	NULL
staining	NULL
for	NULL
IL-4	NULL
(	NULL
top	NULL
panels	NULL
)	NULL
and	NULL
IL-2	NULL
(	NULL
bot-tom	NULL
panels	NULL
)	NULL
on	NULL
the	NULL
y-axis	NULL
.	NULL

levels	NULL
of	NULL
IL-4	NULL
in	NULL
individual	NULL
T	NULL
cells	NULL
were	NULL
only	NULL
detected	NULL
among	NULL
the	NULL
primed	NULL
CD4	NULL
T	NULL
cell	NULL
population	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
both	NULL
primed	NULL
and	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
made	NULL
IL-2	NULL
(	NULL
78	NULL
%	NULL
and	NULL
72	NULL
%	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
and	NULL
most	NULL
IL-2-ex-pressing	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
contained	NULL
more	NULL
IL-2	NULL
on	NULL
a	NULL
per	NULL
cell	NULL
basis	NULL
than	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Memory/effector	NULL
cell	NULL
markers	NULL
,	NULL
such	NULL
as	NULL
CD29	NULL
(	NULL
B	NULL
,	NULL
integrin	NULL
chain	NULL
)	NULL
,	NULL
were	NULL
present	NULL
at	NULL
high	NULL
levels	NULL
on	NULL
usually	NULL
<	NULL
15	NULL
%	NULL
of	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
almost	NULL
all	NULL
(	NULL
>	NULL
95	NULL
%	NULL
)	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
expressed	NULL
these	NULL
markers	NULL
at	NULL
high	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
IL-4	NULL
production	NULL
by	NULL
priming	NULL
was	NULL
due	NULL
both	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
frequency	NULL
of	NULL
the	NULL
IL-4-producing	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
amount	NULL
of	NULL
IL-4	NULL
produced	NULL
per	NULL
cell	NULL
.	NULL

It	NULL
seems	NULL
unlikely	NULL
that	NULL
we	NULL
were	NULL
selectively	NULL
expanding	NULL
a	NULL
subset	NULL
of	NULL
IL-4-producing	NULL
€D4	NULL
T	NULL
cells	NULL
that	NULL
do	NULL
not	NULL
also	NULL
make	NULL
IL-2	NULL
,	NULL
since	NULL
other	NULL
investigators	NULL
have	NULL
shown	NULL
that	NULL
approximately	NULL
half	NULL
of	NULL
the	NULL
IL-4-producing	NULL
CD4	NULL
T	NULL
cells	NULL
also	NULL
expressed	NULL
IL-2	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
fresh	NULL
and	NULL
primed	NULL
bulk	NULL
CD4	NULL
T	NULL
cell	NULL
populations	NULL
are	NULL
polyclonal	NULL
and	NULL
display	NULL
some	NULL
heterogeneity	NULL
of	NULL
cytokine	NULL
production	NULL
at	NULL
the	NULL
single	NULL
cell	NULL
level	NULL
,	NULL
these	NULL
two	NULL
cell	NULL
populations	NULL
provide	NULL
a	NULL
useful	NULL
model	NULL
for	NULL
molecular	NULL
analysis	NULL
of	NULL
how	NULL
priming	NULL
selectively	NULL
increases	NULL
the	NULL
expression	NULL
of	NULL
IL-4	NULL
relative	NULL
to	NULL
IL-2	NULL
.	NULL

IL-4	NULL
promoter	NULL
activity	NULL
is	NULL
greater	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
than	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
The	NULL
recent	NULL
development	NULL
of	NULL
a	NULL
protocol	NULL
for	NULL
transient	NULL
transfection	NULL
of	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
allowed	NULL
us	NULL
to	NULL
analyze	NULL
IL-4	NULL
promoter-driven	NULL
A	NULL
.	NULL

B	NULL
.	NULL

Fresh	NULL
CD4	NULL
T	NULL
Cells	NULL
|	NULL
A	NULL
Primed	NULL
CD4	NULL
T	NULL
Cells	NULL
m	NULL
&	NULL
i	NULL
30	NULL
207	NULL
Arbitrary	NULL
Light	NULL
Units	NULL
(	NULL
x10°	NULL
)	NULL
Relative	NULL
Luciferase	NULL
Units	NULL
(	NULL
x103	NULL
)	NULL
EFI-	NULL
o	NULL
Le	NULL
.	NULL

w	NULL
am	NULL
E	NULL
Fresh	NULL
CD4	NULL
T	NULL
Cells	NULL
257	NULL
M	NULL
Primed	NULL
CD4	NULL
T	NULL
Cells	NULL
plL-4	NULL
200-	NULL
|	NULL
+	NULL
«	NULL
+	NULL
2	NULL
13	NULL
1	NULL
a8	NULL
200-4	NULL
a	NULL
72	NULL
2	NULL
78	NULL
1504	NULL
si	NULL
:	NULL
o	NULL
104	NULL
00	NULL
b	NULL
ae	NULL
so	NULL
{	NULL
--	NULL
a	NULL
{	NULL
*	NULL
6	NULL
2	NULL
b	NULL
-	NULL
22	NULL
1	NULL
§	NULL
19	NULL
6	NULL
&	NULL
wo	NULL
150	NULL
ato	NULL
aho	NULL
so	NULL
100	NULL
150	NULL
abo	NULL
250	NULL
aCDsE-FITC	NULL
all-4-PE	NULL
#	NULL
&	NULL
reporter	NULL
gene	NULL
constructs	NULL
in	NULL
nontransformed	NULL
bulk	NULL
populations	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
27	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Primed	NULL
and	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
compared	NULL
for	NULL
their	NULL
abilities	NULL
to	NULL
transcribe	NULL
,	NULL
after	NULL
transient	NULL
transfection	NULL
,	NULL
a	NULL
reporter	NULL
gene	NULL
construct	NULL
(	NULL
pIL-4-Luc	NULL
,	NULL
containing	NULL
0.8	NULL
kb	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flank	NULL
human	NULL
IL-4	NULL
promoter	NULL
)	NULL
.	NULL

This	NULL
determined	NULL
whether	NULL
the	NULL
increased	NULL
IL-4	NULL
mRNA	NULL
and	NULL
protein	NULL
levels	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
due	NULL
to	NULL
an	NULL
increased	NULL
level	NULL
of	NULL
transcription	NULL
conferred	NULL
by	NULL
the	NULL
5	NULL
'	NULL
flank	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
both	NULL
cell	NULL
types	NULL
were	NULL
also	NULL
analyzed	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
transcribe	NULL
a	NULL
corresponding	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
proximal	NULL
human	NULL
IL-2	NULL
promoter	NULL
(	NULL
pIL-2-Luc	NULL
)	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
luciferase	NULL
detected	NULL
using	NULL
the	NULL
pIL-4-Luc	NULL
construct	NULL
between	NULL
the	NULL
primed	NULL
and	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
was	NULL
substantially	NULL
greater	NULL
(	NULL
17-fold	NULL
)	NULL
than	NULL
the	NULL
ratio	NULL
obtained	NULL
with	NULL
pIL-2-Lue	NULL
construct	NULL
(	NULL
3.4-fold	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

To	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
between	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
,	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
analyzed	NULL
for	NULL
expression	NULL
of	NULL
GFP	NULL
and	NULL
luciferase	NULL
reporter	NULL
genes	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
immediate-early	NULL
CMV	NULL
promoter	NULL
.	NULL

In	NULL
three	NULL
separate	NULL
FCF	NULL
analyses	NULL
,	NULL
0.57	NULL
+	NULL
0.16	NULL
%	NULL
of	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
and	NULL
1.54	NULL
+	NULL
0.64	NULL
%	NULL
of	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
expressed	NULL
GFP	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
transfection	NULL
efficiency	NULL
of	NULL
primed	NULL
cells	NULL
was	NULL
typically	NULL
about	NULL
3-fold	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
fresh	NULL
cells	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
GFP	NULL
and	NULL
luciferase	NULL
were	NULL
determined	NULL
in	NULL
parallel	NULL
,	NULL
and	NULL
the	NULL
ratio	NULL
of	NULL
pCMV-Luc	NULL
activity	NULL
of	NULL
primed	NULL
to	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
was	NULL
virtually	NULL
identical	NULL
to	NULL
the	NULL
ratio	NULL
of	NULL
primed	NULL
to	NULL
fresh	NULL
cells	NULL
which	NULL
were	NULL
GFP	NULL
*	NULL
.	NULL

The	NULL
correlation	NULL
coefficient	NULL
(	NULL
R	NULL
)	NULL
between	NULL
the	NULL
absolute	NULL
values	NULL
of	NULL
arbitrary	NULL
luciferase	NULL
light	NULL
units	NULL
and	NULL
the	NULL
percentages	NULL
of	NULL
GFP-positive	NULL
cells	NULL
for	NULL
©	NULL
o	NULL
©	NULL
m	NULL
in	NULL
o	NULL
i	NULL
i	NULL
i	NULL
®	NULL
plL-4	NULL
to	NULL
pIL-2	NULL
Luciferase	NULL
Ratio	NULL
to	NULL
0.27	NULL
R	NULL
s	NULL
%	NULL
.	NULL

f	NULL
0	NULL
pIL-2	NULL
Fresh	NULL
Primed	NULL
CD4	NULL
T	NULL
Cells	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
Increased	NULL
levels	NULL
of	NULL
IL-4	NULL
by	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
are	NULL
controlled	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

A	NULL
,	NULL
Fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
and	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
for	NULL
5	NULL
h.	NULL
Arbitrary	NULL
light	NULL
units	NULL
from	NULL
fresh	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
and	NULL
primed	NULL
(	NULL
cross-hatched	NULL
)	NULL
CD4	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
pIL-4-Luc	NULL
(	NULL
Zef	NULL
?	NULL
)	NULL

or	NULL
pIL-2-Luc	NULL
(	NULL
right	NULL
)	NULL
are	NULL
presented	NULL
with	NULL
SEs	NULL
of	NULL
the	NULL
means	NULL
for	NULL
one	NULL
representative	NULL
experiment	NULL
.	NULL

The	NULL
background	NULL
from	NULL
the	NULL
control	NULL
vector	NULL
,	NULL
pGL2-Basic	NULL
,	NULL
was	NULL
subtracted	NULL
for	NULL
all	NULL
values	NULL
.	NULL

B	NULL
,	NULL
Arbitrary	NULL
light	NULL
units	NULL
for	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
from	NULL
A	NULL
were	NULL
corrected	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Absolute	NULL
values	NULL
were	NULL
divided	NULL
by	NULL
the	NULL
ratio	NULL
of	NULL
pCMV-Luc	NULL
activity	NULL
obtained	NULL
with	NULL
primed	NULL
and	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

C	NULL
,	NULL
Ratio	NULL
of	NULL
pIL-4-Luc	NULL
to	NULL
pIL-2-Luc	NULL
arbitrary	NULL
light	NULL
units	NULL
from	NULL
fresh	NULL
and	NULL
primed	NULL
(	NULL
right	NULL
)	NULL
CD4	NULL
T	NULL
cells	NULL
plotted	NULL
as	NULL
individual	NULL
experiments	NULL
,	NULL
and	NULL
as	NULL
means	NULL
+	NULL
SDs	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
864	NULL
both	NULL
populations	NULL
was	NULL
0.966	NULL
(	NULL
p	NULL
=	NULL
0.002	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
ratio	NULL
of	NULL
CMV	NULL
promoter-directed	NULL
luciferase	NULL
activity	NULL
between	NULL
the	NULL
primed	NULL
and	NULL
fresh	NULL
T	NULL
cells	NULL
was	NULL
used	NULL
to	NULL
correct	NULL
for	NULL
their	NULL
relative	NULL
transfection	NULL
efficiency	NULL
in	NULL
subsequent	NULL
experiments	NULL
.	NULL

IL-2	NULL
promoter	NULL
activity	NULL
was	NULL
similar	NULL
in	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
when	NULL
the	NULL
luciferase	NULL
light	NULL
units	NULL
were	NULL
corrected	NULL
for	NULL
transfection	NULL
efficiency	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
IL-4	NULL
promoter	NULL
activity	NULL
was	NULL
approximately	NULL
3.5-fold	NULL
greater	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
compared	NULL
with	NULL
fresh	NULL
cells	NULL
.	NULL

We	NULL
also	NULL
determined	NULL
the	NULL
ratio	NULL
of	NULL
pIL-4-Luc	NULL
to	NULL
pIL-2-Luc	NULL
luciferase	NULL
activity	NULL
for	NULL
either	NULL
primed/effector	NULL
or	NULL
fresh	NULL
T	NULL
cells	NULL
,	NULL
a	NULL
value	NULL
that	NULL
is	NULL
not	NULL
influenced	NULL
by	NULL
differences	NULL
in	NULL
transfection	NULL
efficiency	NULL
for	NULL
these	NULL
two	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
pIL-4-Lue	NULL
to	NULL
pIL-2-Luc	NULL
in	NULL
multiple	NULL
experiments	NULL
was	NULL
0.35	NULL
+	NULL
0.09	NULL
for	NULL
the	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
0.09	NULL
+	NULL
0.06	NULL
for	NULL
the	NULL
fresh	NULL
€D4	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
;	NULL
p	NULL
=	NULL
0.002	NULL
,	NULL
by	NULL
the	NULL
two-tailed	NULL
,	NULL
unpaired	NULL
Student	NULL
's	NULL
¢	NULL
test	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggested	NULL
that	NULL
increased	NULL
IL-4	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
by	NULL
primed	NULL
T	NULL
cells	NULL
were	NULL
due	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
to	NULL
an	NULL
enhanced	NULL
level	NULL
of	NULL
IL-4	NULL
gene	NULL
transcription	NULL
directed	NULL
by	NULL
the	NULL
elements	NULL
within	NULL
the	NULL
0.8-kb	NULL
segment	NULL
of	NULL
the	NULL
proximal	NULL
IL-4	NULL
promoter	NULL
.	NULL

They	NULL
also	NULL
indicated	NULL
that	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
,	NULL
pGL2-Basic	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
was	NULL
stronger	NULL
than	NULL
that	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
in	NULL
both	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
immediate	NULL
5	NULL
'	NULL
flank	NULL
promoter	NULL
regions	NULL
of	NULL
the	NULL
IL-4	NULL
and	NULL
IL-2	NULL
genes	NULL
mediated	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
differences	NULL
in	NULL
their	NULL
transcription	NULL
by	NULL
primed	NULL
vs	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
two	NULL
P	NULL
elements	NULL
most	NULL
proximal	NULL
to	NULL
the	NULL
TSS	NULL
are	NULL
engaged	NULL
in	NULL
vivo	NULL
after	NULL
cell	NULL
activation	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
Since	NULL
the	NULL
region	NULL
immediately	NULL
5	NULL
'	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
TSS	NULL
appears	NULL
critical	NULL
for	NULL
activation-induced	NULL
expression	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
47-52	NULL
)	NULL
,	NULL
a	NULL
plausible	NULL
mechanism	NULL
for	NULL
the	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
in	NULL
primed	NULL
,	NULL
compared	NULL
with	NULL
fresh	NULL
,	NULL
CD4	NULL
T	NULL
cells	NULL
would	NULL
be	NULL
increased	NULL
binding	NULL
of	NULL
transcriptional	NULL
activator	NULL
proteins	NULL
to	NULL
this	NULL
region	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
used	NULL
in	NULL
vivo	NULL
footprinting	NULL
to	NULL
compare	NULL
engagement	NULL
of	NULL
this	NULL
region	NULL
by	NULL
proteins	NULL
in	NULL
these	NULL
two	NULL
cell	NULL
types	NULL
before	NULL
and	NULL
after	NULL
polyclonal	NULL
activation	NULL
for	NULL
2	NULL
h	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

A	NULL
striking	NULL
finding	NULL
was	NULL
that	NULL
footprints	NULL
were	NULL
detected	NULL
over	NULL
both	NULL
the	NULL
PO	NULL
and	NULL
P1	NULL
elements	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
following	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
indicating	NULL
protein	NULL
binding	NULL
to	NULL
these	NULL
sites	NULL
in	NULL
vivo	NULL
.	NULL

Previous	NULL
in	NULL
vitro	NULL
studies	NULL
using	NULL
nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
activated	NULL
T	NULL
cells	NULL
have	NULL
indicated	NULL
that	NULL
both	NULL
of	NULL
these	NULL
sites	NULL
bind	NULL
proteins	NULL
of	NULL
the	NULL
NFAT	NULL
transcription	NULL
factor	NULL
family	NULL
(	NULL
53	NULL
,	NULL
54	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
such	NULL
footprints	NULL
were	NULL
detectable	NULL
in	NULL
multiple	NULL
experiments	NULL
using	NULL
polyclonally	NULL
activated	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
most	NULL
likely	NULL
due	NULL
to	NULL
the	NULL
low	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
this	NULL
population	NULL
expressing	NULL
IL-4	NULL
and	NULL
the	NULL
semiquantitative	NULL
nature	NULL
of	NULL
the	NULL
PCR	NULL
amplification	NULL
process	NULL
used	NULL
during	NULL
in	NULL
vivo	NULL
footprinting	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Such	NULL
footprints	NULL
were	NULL
also	NULL
not	NULL
observed	NULL
in	NULL
unstimulated	NULL
fresh	NULL
or	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
that	NULL
the	NULL
pattern	NULL
of	NULL
bands	NULL
in	NULL
this	NULL
region	NULL
were	NULL
similar	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
purified	NULL
human	NULL
genomic	NULL
DNA	NULL
exhaustively	NULL
methylated	NULL
in	NULL
vitro	NULL
.	NULL

Clear	NULL
footprints	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
were	NULL
also	NULL
detectable	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
putative	NULL
c-maf	NULL
response	NULL
element	NULL
,	NULL
a	NULL
site	NULL
implicated	NULL
in	NULL
expression	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
by	NULL
Th2	NULL
cells	NULL
(	NULL
55	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
immediately	NULL
3	NULL
'	NULL
of	NULL
this	NULL
site	NULL
in	NULL
primed	NULL
but	NULL
not	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
octamer-binding	NULL
site	NULL
(	NULL
Oct	NULL
)	NULL
located	NULL
between	NULL
PO	NULL
and	NULL
P1	NULL
was	NULL
footprinted	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
before	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
,	NULL
but	NULL
became	NULL
hypersensitive	NULL
relative	NULL
to	NULL
unstimulated	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
after	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
activation	NULL
resulted	NULL
in	NULL
the	NULL
release	NULL
of	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
bound	NULL
to	NULL
this	NULL
site	NULL
.	NULL

Moreover	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
Oct	NULL
site	NULL
within	NULL
the	NULL
context	NULL
of	NULL
an	NULL
otherwise	NULL
unperturbed	NULL
pIL-4-Luc	NULL
reporter	NULL
gene	NULL
resulted	NULL
in	NULL
increased	NULL
transcriptional	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similar	NULL
repression	NULL
of	NULL
transcription	NULL
by	NULL
octamer	NULL
engagement	NULL
preventing	NULL
binding	NULL
of	NULL
a	NULL
NFAT	NULL
ENHANCES	NULL
IL-4	NULL
IN	NULL
PRIMED	NULL
CD4	NULL
T	NULL
CELLS	NULL
A	NULL
.	NULL

B.	NULL
P	NULL
;	NULL
Oct	NULL
Py	NULL
Maf	NULL
TATA	NULL
ill	NULL
l	NULL
!	NULL

’	NULL
|	NULL
DNA	NULL
20	NULL
i	NULL
L	NULL
Hou	NULL
in	NULL
vitro	NULL
4	NULL
I	NULL
T.	NULL
Primed	NULL
P	NULL
ata	NULL
Unstim	NULL
.	NULL

I	NULL
l	NULL
l	NULL
'	NULL
l	NULL
Primed	NULL
Stim	NULL
.	NULL

«	NULL
tt	NULL
«	NULL
oof	NULL
of	NULL
TTE	NULL
:	NULL
P	NULL
\	NULL
i	NULL
Unstim	NULL
.	NULL

H	NULL
]	NULL
;	NULL
l	NULL
I	NULL
i	NULL
I	NULL
Fresh	NULL
|	NULL
Stim	NULL
.	NULL

c_	NULL
F	NULL
,	NULL
-	NULL
Oc	NULL
``	NULL
Py	NULL
-	NULL
Mal	NULL
-	NULL
TATA	NULL
Arbitrary	NULL
Light	NULL
Units	NULL
(	NULL
x10°	NULL
)	NULL
5	NULL
s	NULL
pll4	NULL
-	NULL
PD	NULL
_-	NULL
Pi	NULL
Mutant	NULL
-	NULL
Mutant	NULL
FIGURE	NULL
3	NULL
.	NULL

The	NULL
proximal	NULL
NFAT-binding	NULL
sites	NULL
(	NULL
P	NULL
elements	NULL
)	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
are	NULL
bound	NULL
in	NULL
vivo	NULL
after	NULL
activation	NULL
and	NULL
are	NULL
critical	NULL
for	NULL
optimal	NULL
IL-4	NULL
expression	NULL
.	NULL

A	NULL
,	NULL
The	NULL
noncoding	NULL
strand	NULL
of	NULL
the	NULL
proximal	NULL
IL-4	NULL
promoter	NULL
was	NULL
analyzed	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
of	NULL
primed	NULL
(	NULL
above	NULL
)	NULL
and	NULL
fresh	NULL
(	NULL
below	NULL
)	NULL
CD4	NULL
T	NULL
cells	NULL
before	NULL
(	NULL
Unstim	NULL
.	NULL
)	NULL

and	NULL
after	NULL
activation	NULL
(	NULL
Stim	NULL
.	NULL
)	NULL

with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
for	NULL
2	NULL
h.	NULL
Sites	NULL
of	NULL
protein	NULL
binding	NULL
(	NULL
footprints	NULL
)	NULL
are	NULL
depicted	NULL
by	NULL
arrows	NULL
,	NULL
and	NULL
hypermethylated	NULL
sites	NULL
are	NULL
represented	NULL
by	NULL
diamonds	NULL
.	NULL

The	NULL
A/G	NULL
cleavage	NULL
pattern	NULL
for	NULL
genomic	NULL
DNA	NULL
(	NULL
in	NULL
vitro	NULL
)	NULL
is	NULL
presented	NULL
for	NULL
comparison	NULL
(	NULL
fop	NULL
)	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
more	NULL
than	NULL
four	NULL
independent	NULL
experiments	NULL
for	NULL
each	NULL
cell	NULL
type	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
the	NULL
hypermethylated	NULL
band	NULL
in	NULL
P1	NULL
(	NULL
far	NULL
left	NULL
diamond	NULL
)	NULL
was	NULL
footprinted	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

P1	NULL
and	NULL
PO	NULL
represent	NULL
the	NULL
most	NULL
proximal	NULL
NFAT	NULL
binding	NULL
sites	NULL
;	NULL
Oct	NULL
is	NULL
a	NULL
putative	NULL
octamer	NULL
binding	NULL
site	NULL
;	NULL
Maf	NULL
is	NULL
a	NULL
putative	NULL
binding	NULL
site	NULL
for	NULL
c-maf	NULL
,	NULL
TATA	NULL
is	NULL
the	NULL
TATA	NULL
box	NULL
region	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

B	NULL
,	NULL
Primed	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
and	NULL
activated	NULL
for	NULL
5	NULL
h	NULL
,	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
with	NULL
pIL-4-Luc	NULL
or	NULL
the	NULL
identical	NULL
plasmid	NULL
mutated	NULL
at	NULL
the	NULL
PO	NULL
or	NULL
P1	NULL
sites	NULL
.	NULL

Arbitrary	NULL
light	NULL
units	NULL
,	NULL
minus	NULL
the	NULL
background	NULL
from	NULL
pGL2-Basic	NULL
(	NULL
means	NULL
+	NULL
the	NULL
SEs	NULL
)	NULL
,	NULL
are	NULL
shown	NULL
that	NULL
are	NULL
representative	NULL
of	NULL
more	NULL
than	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

nearby	NULL
transcriptional	NULL
activator	NULL
,	NULL
before	NULL
cell	NULL
activation	NULL
,	NULL
has	NULL
been	NULL
observed	NULL
for	NULL
the	NULL
IL-8	NULL
promoter	NULL
(	NULL
56	NULL
)	NULL
,	NULL
but	NULL
a	NULL
recent	NULL
report	NULL
suggests	NULL
that	NULL
octamer	NULL
binding	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
PO	NULL
element	NULL
engagement	NULL
,	NULL
may	NULL
actually	NULL
increase	NULL
IL-4	NULL
promoter	NULL
activity	NULL
in	NULL
a	NULL
T	NULL
cell	NULL
clone	NULL
(	NULL
57	NULL
)	NULL
.	NULL

This	NULL
discrepancy	NULL
may	NULL
reflect	NULL
differences	NULL
between	NULL
T	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
propagated	NULL
in	NULL
vitro	NULL
for	NULL
short	NULL
vs	NULL
long	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

None-theless	NULL
,	NULL
increased	NULL
human	NULL
IL-4	NULL
promoter	NULL
activity	NULL
by	NULL
primed	NULL
human	NULL
CD4	NULL
T	NULL
cells	NULL
correlated	NULL
with	NULL
increased	NULL
engagement	NULL
of	NULL
PO	NULL
,	NULL
P1	NULL
,	NULL
and	NULL
the	NULL
putative	NULL
c-maf	NULL
response	NULL
element	NULL
,	NULL
and	NULL
decreased	NULL
engagement	NULL
of	NULL
the	NULL
Oct	NULL
cis-element	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
being	NULL
bound	NULL
in	NULL
vivo	NULL
after	NULL
activation	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
,	NULL
previous	NULL
work	NULL
using	NULL
murine	NULL
Th2	NULL
clones	NULL
has	NULL
suggested	NULL
that	NULL
PO	NULL
and	NULL
P1	NULL
are	NULL
each	NULL
critical	NULL
for	NULL
IL-4	NULL
promoter	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
cell	NULL
activation	NULL
(	NULL
53	NULL
,	NULL
54	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
these	NULL
elements	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
critical	NULL
purine	NULL
residues	NULL
of	NULL
PO	NULL
and	NULL
P1	NULL
required	NULL
for	NULL
NFAT	NULL
binding	NULL
(	NULL
53	NULL
,	NULL
58	NULL
)	NULL
were	NULL
mutated	NULL
by	NULL
substitution	NULL
in	NULL
an	NULL
otherwise	NULL
unaltered	NULL
pIL-4-Lue	NULL
construct	NULL
to	NULL
create	NULL
POm-Luc	NULL
and	NULL
Pim-Luc	NULL
,	NULL
respectively	NULL
.	NULL

Each	NULL
mutant	NULL
construct	NULL
decreased	NULL
IL-4	NULL
expression	NULL
by	NULL
>	NULL
75	NULL
%	NULL
in	NULL
multiple	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
each	NULL
of	NULL
these	NULL
NFAT	NULL
binding	NULL
sites	NULL
was	NULL
important	NULL
for	NULL
optimal	NULL
transcription	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
in	NULL
nontransformed	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Primed	NULL
T	NULL
cell	NULL
nuclei	NULL
are	NULL
enriched	NULL
for	NULL
NFAT1	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
IL-4	NULL
P1	NULL
element	NULL
Since	NULL
the	NULL
proximal	NULL
NFAT-binding	NULL
sites	NULL
appeared	NULL
critical	NULL
for	NULL
IL-4	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
determined	NULL
if	NULL
specific	NULL
binding	NULL
of	NULL
nuclear	NULL
protein	NULL
,	NULL
from	NULL
primed	NULL
vs	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
to	NULL
P	NULL
elements	NULL
in	NULL
vitro	NULL
correlated	NULL
with	NULL
IL-4	NULL
promoter	NULL
activity	NULL
and	NULL
gene	NULL
expression	NULL
.	NULL

Primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
rested	NULL
for	NULL
3	NULL
days	NULL
by	NULL
incubation	NULL
in	NULL
medium	NULL
without	NULL
exogenous	NULL
recombinant	NULL
IL-2	NULL
,	NULL
contained	NULL
significant	NULL
levels	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
865	NULL
+	NULL
D.	NULL
IL-4	NULL
P1	NULL
Probe	NULL
IL-4	NULL
P1	NULL
Probe	NULL
AP-1	NULL
Probe	NULL
Activated	NULL
T	NULL
cells	NULL
Primed	NULL
T	NULL
cells	NULL
Primed	NULL
Fresh	NULL
Activated	NULL
T	NULL
cells	NULL
Protein	NULL
:	NULL
_	NULL
Nuclear	NULL
Total	NULL
ition	NULL
:	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+-	NULL
j	NULL
r	NULL
a	NULL
Competition	NULL
:	NULL
-	NULL
+	NULL
-	NULL
+	NULL
mﬁgﬁ	NULL
?	NULL

T2	NULL
J	NULL
Z	NULL
Primed	NULL
-	NULL
Fresh	NULL
Stimulation	NULL
:	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
Activation	NULL
:	NULL
-	NULL
-	NULL
+	NULL
+	NULL
NFATA1	NULL
peptide	NULL
:	NULL
-	NULL
-	NULL
&	NULL
+	NULL
-	NULL
-	NULL
-	NULL
_	NULL
Competition	NULL
:	NULL
-	NULL
+	NULL
ns	NULL
-	NULL
+	NULL
ns	NULL
_	NULL
CD4T	NULL
cell	NULL
type	NULL
:	NULL
Fr	NULL
Fr	NULL
Pr	NULL
Pr	NULL
Fr	NULL
Pr	NULL
'	NULL
Supershifted-	NULL
»	NULL
-	NULL
_	NULL
#	NULL
#	NULL
kDa	NULL
a	NULL
.	NULL

P	NULL
NFAT1	NULL
w	NULL
#	NULL
-	NULL
&	NULL
200	NULL
w*	NULL
«	NULL
a	NULL
or	NULL
~g=m	NULL
123	NULL
-	NULL
#	NULL
w	NULL
#	NULL
as	NULL
...	NULL
Free	NULL
probe	NULL
*	NULL
Free	NULL
>	NULL
probe	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Primed	NULL
CD4	NULL
T	NULL
cells	NULL
have	NULL
increased	NULL
levels	NULL
of	NULL
NFAT1	NULL
in	NULL
the	NULL
nucleus	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
human	NULL
IL-4	NULL
P1	NULL
element	NULL
.	NULL

A	NULL
,	NULL
Nuclear	NULL
protein	NULL
from	NULL
primed	NULL
T	NULL
cells	NULL
,	NULL
before	NULL
(	NULL
-	NULL
)	NULL
or	NULL
after	NULL
(	NULL
+	NULL
)	NULL
polyclonal	NULL
activation	NULL
for	NULL
2	NULL
h	NULL
,	NULL
was	NULL
reacted	NULL
with	NULL
an	NULL
IL-4	NULL
P1	NULL
oligonucleotide	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Lanes	NULL
2	NULL
and	NULL
4	NULL
represent	NULL
nuclear	NULL
protein	NULL
preincubated	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
P1	NULL
oligonucleotide	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
free	NULL
(	NULL
unbound	NULL
)	NULL
labeled	NULL
probe	NULL
is	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
using	NULL
nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
activated	NULL
primed	NULL
(	NULL
Zeft	NULL
lanes	NULL
)	NULL
and	NULL
fresh	NULL
(	NULL
right	NULL
lanes	NULL
)	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
IL-4	NULL
P1	NULL
element	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

The	NULL
specificity	NULL
was	NULL
confirmed	NULL
in	NULL
lane	NULL
5	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
the	NULL
identical	NULL
unlabeled	NULL
probe	NULL
.	NULL

For	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
6	NULL
,	NULL
the	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
antiserum	NULL
specific	NULL
for	NULL
NFAT1	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
antiserum-induced	NULL
supershifts	NULL
was	NULL
confirmed	NULL
in	NULL
lane	NULL
3	NULL
by	NULL
preincu-bating	NULL
the	NULL
antiserum	NULL
with	NULL
the	NULL
peptide	NULL
against	NULL
which	NULL
it	NULL
was	NULL
generated	NULL
.	NULL

C	NULL
,	NULL
Nuclear	NULL
protein	NULL
from	NULL
activated	NULL
primed	NULL
(	NULL
Zef	NULL
?	NULL
)	NULL

and	NULL
fresh	NULL
(	NULL
right	NULL
)	NULL
T	NULL
cells	NULL
was	NULL
analyzed	NULL
by	NULL
EMSA	NULL
using	NULL
an	NULL
AP-1	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
complex	NULL
was	NULL
confirmed	NULL
by	NULL
inhibition	NULL
of	NULL
complex	NULL
formation	NULL
by	NULL
preincubation	NULL
of	NULL
the	NULL
protein	NULL
extracts	NULL
with	NULL
the	NULL
identical	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
but	NULL
not	NULL
an	NULL
unrelated	NULL
,	NULL
nonspecific	NULL
(	NULL
ns	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
,	NULL
unlabeled	NULL
competitor	NULL
oligonucleotide	NULL
.	NULL

D	NULL
,	NULL
A	NULL
Western	NULL
blot	NULL
of	NULL
nuclear	NULL
(	NULL
eff	NULL
lanes	NULL
)	NULL
and	NULL
total	NULL
protein	NULL
(	NULL
right	NULL
lanes	NULL
)	NULL
from	NULL
fresh	NULL
(	NULL
Fr	NULL
)	NULL
and	NULL
primed	NULL
(	NULL
Pr	NULL
)	NULL
CD4	NULL
T	NULL
cells	NULL
before	NULL
(	NULL
-	NULL
)	NULL
and	NULL
after	NULL
(	NULL
+	NULL
)	NULL
activation	NULL
,	NULL
probed	NULL
with	NULL
antiserum	NULL
to	NULL
NFAT1	NULL
.	NULL

The	NULL
migratory	NULL
positions	NULL
of	NULL
standard	NULL
m.w	NULL
.	NULL

markers	NULL
are	NULL
indicated	NULL
in	NULL
kDa	NULL
to	NULL
the	NULL
left	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

of	NULL
nuclear	NULL
protein	NULL
that	NULL
bound	NULL
in	NULL
vitro	NULL
to	NULL
the	NULL
human	NULL
IL-4	NULL
P1	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
what	NULL
was	NULL
found	NULL
by	NULL
Wenner	NULL
et	NULL
al	NULL
.	NULL

(	NULL
59	NULL
)	NULL
and	NULL
Rincon	NULL
and	NULL
Flavell	NULL
(	NULL
60	NULL
)	NULL
.	NULL

Polyclonal	NULL
activation	NULL
of	NULL
the	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
for	NULL
2	NULL
h	NULL
further	NULL
increased	NULL
this	NULL
level	NULL
of	NULL
protein	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

This	NULL
binding	NULL
was	NULL
specific	NULL
in	NULL
that	NULL
addition	NULL
of	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
self-oligonucleotide	NULL
competed	NULL
for	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
found	NULL
no	NULL
evidence	NULL
for	NULL
contaminating	NULL
cytoplasmic	NULL
protein	NULL
since	NULL
the	NULL
same	NULL
nuclear	NULL
extract	NULL
had	NULL
no	NULL
detectable	NULL
lactate	NULL
dehydrogenase	NULL
(	NULL
a	NULL
strictly	NULL
cytosolic	NULL
protein	NULL
)	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
whereas	NULL
lactate	NULL
dehydrogenase	NULL
was	NULL
easily	NULL
detected	NULL
in	NULL
whole	NULL
cell	NULL
extracts	NULL
from	NULL
the	NULL
same	NULL
cell	NULL
population	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Antiserum	NULL
to	NULL
NFAT1	NULL
was	NULL
used	NULL
during	NULL
EMSA	NULL
to	NULL
determine	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
nuclear	NULL
proteins	NULL
from	NULL
activated	NULL
primed	NULL
T	NULL
cells	NULL
bound	NULL
to	NULL
the	NULL
human	NULL
IL-4	NULL
P1	NULL
element	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
the	NULL
complex	NULL
bound	NULL
to	NULL
the	NULL
human	NULL
IL-4	NULL
P1	NULL
was	NULL
supershifted	NULL
with	NULL
NFAT1-specific	NULL
antiserum	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
supershift	NULL
was	NULL
specific	NULL
since	NULL
preincubation	NULL
of	NULL
the	NULL
antiserum	NULL
with	NULL
the	NULL
peptide	NULL
against	NULL
which	NULL
it	NULL
was	NULL
made	NULL
completely	NULL
abrogated	NULL
the	NULL
supershift	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
bound	NULL
to	NULL
the	NULL
human	NULL
IL-4	NULL
P1	NULL
element	NULL
were	NULL
demonstrated	NULL
to	NULL
not	NULL
be	NULL
the	NULL
common	NULL
,	NULL
NFAT-related	NULL
,	NULL
NF-KB	NULL
proteins	NULL
(	NULL
c-Rel	NULL
,	NULL
Rel	NULL
A	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
)	NULL
by	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
specific	NULL
antisera	NULL
to	NULL
these	NULL
proteins	NULL
by	NULL
gel	NULL
shift	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
very	NULL
little	NULL
complex	NULL
with	NULL
the	NULL
human	NULL
IL-4	NULL
P1	NULL
element	NULL
was	NULL
detected	NULL
using	NULL
an	NULL
equivalent	NULL
quantity	NULL
of	NULL
nuclear	NULL
protein	NULL
from	NULL
activated	NULL
fresh	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
small	NULL
amount	NULL
detected	NULL
,	NULL
however	NULL
,	NULL
was	NULL
specific	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
and	NULL
predominantly	NULL
supershifted	NULL
by	NULL
the	NULL
NFAT1-specific	NULL
antiserum	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
recent	NULL
results	NULL
by	NULL
Lykah	NULL
et	NULL
al	NULL
.	NULL

(	NULL
61	NULL
)	NULL
and	NULL
Timmerman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
42	NULL
)	NULL
.	NULL

EMSA	NULL
,	NULL
using	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
for	NULL
a	NULL
human	NULL
metallo-thionein	NULL
promoter	NULL
AP-1	NULL
site	NULL
,	NULL
demonstrated	NULL
that	NULL
in	NULL
contrast	NULL
to	NULL
NFAT1	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
there	NULL
were	NULL
roughly	NULL
equivalent	NULL
levels	NULL
of	NULL
AP-1	NULL
protein	NULL
binding	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
primed	NULL
and	NULL
fresh	NULL
human	NULL
T	NULL
cells	NULL
after	NULL
polyclonal	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
I	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
AP-1	NULL
element	NULL
was	NULL
shown	NULL
by	NULL
inhibition	NULL
of	NULL
complex	NULL
formation	NULL
with	NULL
unlabeled	NULL
self	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
nonspecific	NULL
competitor	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
observed	NULL
increased	NULL
NFAT1	NULL
binding	NULL
to	NULL
the	NULL
P1	NULL
element	NULL
in	NULL
primed	NULL
T	NULL
cells	NULL
was	NULL
due	NULL
to	NULL
quantitative	NULL
differ-ences	NULL
,	NULL
nuclear	NULL
and	NULL
total	NULL
protein	NULL
from	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
was	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
using	NULL
an	NULL
NFAT	NULL
!	NULL

-specific	NULL
antiserum	NULL
.	NULL

NFAT1	NULL
was	NULL
barely	NULL
detectable	NULL
,	NULL
as	NULL
either	NULL
a	NULL
110-	NULL
or	NULL
130-kDa	NULL
protein	NULL
,	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

A	NULL
small	NULL
increase	NULL
in	NULL
the	NULL
lower	NULL
m.w	NULL
.	NULL

form	NULL
was	NULL
noticeable	NULL
after	NULL
activation	NULL
,	NULL
and	NULL
this	NULL
may	NULL
represent	NULL
a	NULL
dephos-phorylated	NULL
form	NULL
of	NULL
NFAT1	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
(	NULL
62	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
significant	NULL
levels	NULL
of	NULL
NFAT1	NULL
were	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
unstimulated	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
primarily	NULL
as	NULL
a	NULL
130-kDa	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

After	NULL
polyclonal	NULL
activation	NULL
of	NULL
the	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
130-kDa	NULL
form	NULL
of	NULL
NFAT1	NULL
was	NULL
observed	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
dominant	NULL
form	NULL
of	NULL
~120	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
metabolically	NULL
labeled	NULL
nuclear	NULL
protein	NULL
(	NULL
63	NULL
)	NULL
from	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
confirmed	NULL
that	NULL
the	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
P1	NULL
oligonucleotide	NULL
was	NULL
~115	NULL
kDa	NULL
in	NULL
size	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
significant	NULL
levels	NULL
of	NULL
the	NULL
higher	NULL
m.w	NULL
.	NULL

form	NULL
of	NULL
NFAT1	NULL
were	NULL
detected	NULL
from	NULL
total	NULL
protein	NULL
preparations	NULL
of	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
there	NULL
was	NULL
more	NULL
total	NULL
NFAT1	NULL
detected	NULL
in	NULL
the	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
including	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
110-	NULL
and	NULL
120-kDa	NULL
forms	NULL
,	NULL
possibly	NULL
derived	NULL
from	NULL
the	NULL
nucleus	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
suggested	NULL
that	NULL
quantitative	NULL
and	NULL
,	NULL
possibly	NULL
,	NULL
qualitative	NULL
differences	NULL
in	NULL
nuclear	NULL
NFAT1	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
866	NULL
NFAT	NULL
ENHANCES	NULL
IL-4	NULL
IN	NULL
PRIMED	NULL
CD4	NULL
T	NULL
CELLS	NULL
A	NULL
.	NULL

B.	NULL
C.	NULL
FIGURE	NULL
5	NULL
.	NULL

-	NULL
Priming	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
increases	NULL
601	NULL
&	NULL
Fresh	NULL
CD4	NULL
T	NULL
Cell	NULL
9	NULL
Fresh	NULL
CD4	NULL
T	NULL
Cell	NULL
19	NULL
|	NULL
their	NULL
functional	NULL
NFAT	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
Fresh	NULL
(	NULL
filled	NULL
A	NULL
Pfr	NULL
$	NULL
an	NULL
d	NULL
CD4	NULL
T	NULL
(	NULL
9337	NULL
's	NULL
-	NULL
|g	NULL
P	NULL
’	NULL
rfrfle	NULL
d	NULL
C4	NULL
els	NULL
o	NULL
bars	NULL
)	NULL
and	NULL
primed	NULL
(	NULL
cross-hatched	NULL
)	NULL
CD4	NULL
T	NULL
cells	NULL
3~	NULL
50	NULL
“	NULL
é	NULL
T	NULL
Cells	NULL
§1o-	NULL
8	NULL
were	NULL
transfected	NULL
with	NULL
pAP-1-Luc	NULL
(	NULL
lef	NULL
?	NULL
)	NULL

and	NULL
g	NULL
T	NULL
?	NULL

g	NULL
pNFAT-Luc	NULL
(	NULL
right	NULL
)	NULL
multimer	NULL
plasmids	NULL
and	NULL
acti-	NULL
o	NULL
40	NULL
F=	NULL
g	NULL
84	NULL
vated	NULL
for	NULL
5	NULL
h.	NULL
Arbitrary	NULL
light	NULL
units	NULL
(	NULL
means	NULL
+	NULL
SEs	NULL
)	NULL
E	NULL
ﬂ	NULL
E	NULL
®	NULL
are	NULL
presented	NULL
for	NULL
one	NULL
representative	NULL
experiment	NULL
#	NULL
30	NULL
8	NULL
q	NULL
2	NULL
64	NULL
of	NULL
three	NULL
.	NULL

B	NULL
,	NULL
Values	NULL
from	NULL
A	NULL
for	NULL
primed	NULL
CD4	NULL
T	NULL
3	NULL
%	NULL
3	NULL
:	NULL
cells	NULL
corrected	NULL
for	NULL
transfection	NULL
efficiency	NULL
as	NULL
per	NULL
g	NULL
20	NULL
3	NULL
a	NULL
47	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

C	NULL
,	NULL
Ratio	NULL
of	NULL
pNFAT-Luc	NULL
to	NULL
pAP-1-Luc	NULL
3	NULL
$	NULL
ig	NULL
light	NULL
units	NULL
for	NULL
fresh	NULL
(	NULL
Zef	NULL
?	NULL
)	NULL

or	NULL
primed	NULL
(	NULL
right	NULL
)	NULL
CD4	NULL
T	NULL
<	NULL
10	NULL
é	NULL
4	NULL
24	NULL
<	NULL
p	NULL
a	NULL
cells	NULL
.	NULL

Values	NULL
for	NULL
individual	NULL
experiments	NULL
,	NULL
and	NULL
9	NULL
means	NULL
+	NULL
SDs	NULL
are	NULL
shown	NULL
.	NULL

APA	NULL
___	NULL
NFAT	NULL
APA	NULL
___	NULL
NFAT	NULL
°	NULL
~-	NULL
Frosh	NULL
-	NULL
Primed	NULL
Multimer	NULL
_	NULL
Multimer	NULL
Multimer	NULL
_	NULL
Multimer	NULL
CD4	NULL
T	NULL
Cells	NULL
(	NULL
translational	NULL
or	NULL
posttranslational	NULL
)	NULL
may	NULL
have	NULL
contributed	NULL
to	NULL
the	NULL
increased	NULL
binding	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
P1	NULL
element	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Primed/effector	NULL
CD4	NULL
T	NULL
cells	NULL
have	NULL
more	NULL
functional	NULL
NFAT	NULL
than	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
To	NULL
determine	NULL
whether	NULL
increased	NULL
expression	NULL
of	NULL
NFAT	NULL
protein	NULL
by	NULL
primed	NULL
T	NULL
cells	NULL
correlated	NULL
with	NULL
an	NULL
increased	NULL
capacity	NULL
for	NULL
these	NULL
cells	NULL
to	NULL
direct	NULL
transcription	NULL
via	NULL
NFAT-binding	NULL
cis-elements	NULL
,	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
luciferase	NULL
reporter	NULL
gene	NULL
constructs	NULL
driven	NULL
by	NULL
multimers	NULL
of	NULL
either	NULL
the	NULL
distal	NULL
human	NULL
IL-2	NULL
NFAT	NULL
site	NULL
(	NULL
a	NULL
multimer	NULL
of	NULL
a	NULL
P	NULL
element	NULL
and	NULL
an	NULL
adjacent	NULL
AP-1	NULL
site	NULL
)	NULL
or	NULL
the	NULL
human	NULL
IL-2	NULL
AP-1	NULL
site	NULL
(	NULL
a	NULL
multimer	NULL
of	NULL
an	NULL
AP-1	NULL
binding	NULL
site	NULL
,	NULL
alone	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
NFAT	NULL
multimer	NULL
had	NULL
promoter	NULL
activity	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
,	NULL
it	NULL
was	NULL
significantly	NULL
higher	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
compared	NULL
with	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
even	NULL
when	NULL
promoter	NULL
activities	NULL
were	NULL
corrected	NULL
for	NULL
transfection	NULL
efficiency	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
a	NULL
murine	NULL
IL-4	NULL
promoter-derived	NULL
NFAT	NULL
multimer	NULL
construct	NULL
site	NULL
(	NULL
59	NULL
)	NULL
that	NULL
includes	NULL
the	NULL
P1	NULL
binding	NULL
site	NULL
and	NULL
an	NULL
adjacent	NULL
AP-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
both	NULL
cell	NULL
types	NULL
contained	NULL
similar	NULL
levels	NULL
of	NULL
luciferase	NULL
activity	NULL
after	NULL
transfection	NULL
with	NULL
the	NULL
pAP-1-Lue	NULL
construct	NULL
when	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiency	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
suggested	NULL
that	NULL
the	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
NFAT	NULL
multimer	NULL
compared	NULL
with	NULL
the	NULL
AP-1	NULL
multimer	NULL
in	NULL
A	NULL
.	NULL

-	NULL
B.	NULL
Freshly-Isolated	NULL
Primed	NULL
CD4	NULL
T	NULL
Cells	NULL
__	NULL
87	NULL
CD4	NULL
T	NULL
Cells	NULL
50	NULL
~	NULL
C	NULL
``	NULL
\T	NULL
ser	NULL
To	NULL
“	NULL
%	NULL
~~	NULL
[	NULL
404	NULL
--	NULL
*	NULL
a	NULL
4	NULL
«	NULL
~~	NULL
a	NULL
is	NULL
iS	NULL
2	NULL
304	NULL
2	NULL
5	NULL
47	NULL
``	NULL
6	NULL
G	NULL
204	NULL
>	NULL
I3	NULL
®	NULL
iono	NULL
+	NULL
PMA	NULL
®	NULL
iono	NULL
+	NULL
PMA	NULL
Fol	NULL
€	NULL
21°*	NULL
o	NULL
medium	NULL
0	NULL
medium	NULL
3	NULL
2	NULL
i	NULL
€	NULL
104	NULL
&	NULL
0-4	NULL
t	NULL
t	NULL
t	NULL
0	NULL
-	NULL
#	NULL
Y	NULL
t	NULL
r	NULL
0	NULL
5	NULL
10	NULL
20	NULL
W	NULL
5	NULL
10	NULL
20	NULL
NFAT1	NULL
(	NULL
ug	NULL
)	NULL
NFAT1	NULL
(	NULL
ng	NULL
)	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
was	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
P	NULL
element	NULL
component	NULL
.	NULL

The	NULL
mean	NULL
ratios	NULL
of	NULL
the	NULL
pNFAT-Luc	NULL
to	NULL
the	NULL
pAP-1-Lue	NULL
activity	NULL
in	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
1.5	NULL
+	NULL
0.16	NULL
and	NULL
9.3	NULL
+	NULL
0.88	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

This	NULL
highly	NULL
significant	NULL
difference	NULL
(	NULL
p	NULL
<	NULL
0.001	NULL
by	NULL
the	NULL
two-tailed	NULL
,	NULL
unpaired	NULL
Student	NULL
's	NULL
£	NULL
test	NULL
)	NULL
supports	NULL
the	NULL
idea	NULL
that	NULL
priming	NULL
preferentially	NULL
increased	NULL
P	NULL
element-di-rected	NULL
transcription	NULL
relative	NULL
to	NULL
that	NULL
directed	NULL
by	NULL
AP-1	NULL
elements	NULL
.	NULL

NFAT	NULL
is	NULL
critical	NULL
for	NULL
optimal	NULL
IL-4	NULL
gene	NULL
transcription	NULL
To	NULL
determine	NULL
whether	NULL
increased	NULL
NFAT	NULL
expression	NULL
could	NULL
augment	NULL
IL-4	NULL
promoter	NULL
activity	NULL
in	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
an	NULL
expression	NULL
vector	NULL
for	NULL
NFAT1	NULL
(	NULL
NFAT1/pREP-4	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
pIL-4-Luc	NULL
into	NULL
these	NULL
cell	NULL
types	NULL
.	NULL

Transfection	NULL
of	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
NFAT1/pREP-4	NULL
markedly	NULL
increased	NULL
IL-4	NULL
promoter	NULL
activity	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
,	NULL
achieving	NULL
levels	NULL
of	NULL
activity	NULL
that	NULL
were	NULL
~3.5-fold	NULL
greater	NULL
than	NULL
basal	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

Although	NULL
transfection	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
NFAT1/pREP-4	NULL
plasmid	NULL
into	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
also	NULL
progressively	NULL
increased	NULL
IL-4	NULL
promoter	NULL
activity	NULL
,	NULL
the	NULL
maximal	NULL
enhancement	NULL
of	NULL
promoter	NULL
activity	NULL
was	NULL
relatively	NULL
modest	NULL
compared	NULL
with	NULL
the	NULL
basal	NULL
level	NULL
(	NULL
~1.5-fold	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
low	NULL
endogenous	NULL
levels	NULL
of	NULL
NFAT	NULL
proteins	NULL
in	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
limiting	NULL
for	NULL
IL-4	NULL
promoter	NULL
activity	NULL
,	NULL
while	NULL
these	NULL
levels	NULL
were	NULL
0	NULL
lono	NULL
+	NULL
PMA	NULL
Stimulated	NULL
Primed	NULL
CD4	NULL
T	NULL
Cells	NULL
lono	NULL
+	NULL
PMA	NULL
Stimulated	NULL
Freshly-Isolated	NULL
CD4	NULL
T	NULL
Cells	NULL
&	NULL
co	NULL
m	NULL
ho	NULL
Arbitrary	NULL
Light	NULL
Units	NULL
(	NULL
x103	NULL
)	NULL
plt-4	NULL
__	NULL
pll-4	NULL
_	NULL
pll-4	NULL
plL-4	NULL
plL-4	NULL
plL-4	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Control	NULL
_	NULL
NFAT1	NULL
_	NULL
NFAT	NULL
Control	NULL
-	NULL
NFAT2	NULL
-	NULL
NFAT4	NULL
dom	NULL
.	NULL

neg	NULL
.	NULL

FIGURE	NULL
6	NULL
.	NULL

-	NULL
Levels	NULL
of	NULL
wild-type	NULL
NFAT	NULL
are	NULL
critical	NULL
to	NULL
IL-4	NULL
expression	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Fresh	NULL
(	NULL
/e/	NULL
?	NULL
)	NULL

and	NULL
primed	NULL
(	NULL
right	NULL
)	NULL
CD4	NULL
T	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
pIL-4-Luc	NULL
and	NULL
stimulated	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

An	NULL
expression	NULL
plasmid	NULL
for	NULL
wild-type	NULL
NFAT1	NULL
(	NULL
NFATI/pREP-4	NULL
)	NULL
was	NULL
cotransfected	NULL
at	NULL
various	NULL
concentrations	NULL
of	NULL
plasmid	NULL
(	NULL
0	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
or	NULL
20	NULL
ug	NULL
)	NULL
along	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
pIL-4-Luc	NULL
.	NULL

The	NULL
parent	NULL
expression	NULL
plasmid	NULL
,	NULL
pREP-4	NULL
,	NULL
was	NULL
added	NULL
to	NULL
NFAT1/pREP-4	NULL
so	NULL
that	NULL
the	NULL
total	NULL
quantity	NULL
of	NULL
transfected	NULL
plasmid	NULL
DNA	NULL
was	NULL
equal	NULL
to	NULL
30	NULL
ug	NULL
in	NULL
all	NULL
cases	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
as	NULL
arbitrary	NULL
luciferase	NULL
light	NULL
units	NULL
(	NULL
means	NULL
+	NULL
SEs	NULL
)	NULL
,	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
seven	NULL
similar	NULL
,	NULL
independent	NULL
experiments	NULL
for	NULL
each	NULL
cell	NULL
type	NULL
.	NULL

B	NULL
,	NULL
Primed	NULL
CD4	NULL
T	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
pIL-4-Luc	NULL
and	NULL
cotransfected	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
pREP-4	NULL
(	NULL
control	NULL
)	NULL
,	NULL
NFATL/pREP-4	NULL
(	NULL
NFAT1	NULL
)	NULL
,	NULL
or	NULL
NFAT1ANH	NULL
,	NULL
/pREP-4	NULL
(	NULL
NFAT1	NULL
dom	NULL
.	NULL

neg	NULL
.	NULL
)	NULL

.	NULL

Arbitrary	NULL
luciferase	NULL
light	NULL
units	NULL
(	NULL
means	NULL
+	NULL
SEs	NULL
)	NULL
are	NULL
presented	NULL
for	NULL
one	NULL
experiment	NULL
representative	NULL
of	NULL
five	NULL
performed	NULL
.	NULL

C	NULL
,	NULL
Freshly	NULL
isolated	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
pIL-4-Luc	NULL
and	NULL
cotransfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
pREP-4	NULL
(	NULL
control	NULL
)	NULL
,	NULL
NFAT2/pREP-4	NULL
(	NULL
NFAT2	NULL
)	NULL
,	NULL
or	NULL
NFAT4/pREP-4	NULL
(	NULL
NFAT4	NULL
)	NULL
.	NULL

Arbitrary	NULL
luciferase	NULL
light	NULL
units	NULL
(	NULL
means	NULL
*	NULL
SE	NULL
)	NULL
are	NULL
presented	NULL
for	NULL
one	NULL
experiment	NULL
representative	NULL
of	NULL
four	NULL
performed	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A.	NULL
Stimulation	NULL
:	NULL
FIGURE	NULL
7	NULL
.	NULL

-	NULL
Levels	NULL
of	NULL
NFAT	NULL
!	NULL

and	NULL
NFAT4	NULL
,	NULL
but	NULL
CD4	NULL
T	NULL
cell	NULL
type	NULL
:	NULL
Fr	NULL
not	NULL
NFAT2	NULL
,	NULL
are	NULL
increased	NULL
with	NULL
priming	NULL
of	NULL
CD4	NULL
T	NULL
kDa	NULL
cells	NULL
.	NULL

Western	NULL
blots	NULL
of	NULL
nuclear	NULL
protein	NULL
from	NULL
fresh	NULL
250-	NULL
(	NULL
Fr	NULL
)	NULL
and	NULL
primed	NULL
(	NULL
Pr	NULL
)	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
before	NULL
(	NULL
-	NULL
)	NULL
and	NULL
160-after	NULL
(	NULL
+	NULL
)	NULL
polyclonal	NULL
activation	NULL
with	NULL
ionomycin	NULL
105-and	NULL
PMA	NULL
,	NULL
were	NULL
probed	NULL
with	NULL
Abs	NULL
directed	NULL
against	NULL
T5-NFAT1	NULL
(	NULL
left	NULL
)	NULL
,	NULL
NFAT2	NULL
(	NULL
middle	NULL
)	NULL
,	NULL
and	NULL
NFAT4	NULL
(	NULL
right	NULL
)	NULL
.	NULL

The	NULL
migratory	NULL
positions	NULL
of	NULL
standard	NULL
m.w	NULL
.	NULL

50-markers	NULL
are	NULL
indicated	NULL
in	NULL
kDa	NULL
to	NULL
the	NULL
left	NULL
of	NULL
the	NULL
gels	NULL
.	NULL

25-	NULL
close	NULL
to	NULL
optimal	NULL
for	NULL
directing	NULL
IL-4	NULL
promoter	NULL
activity	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NFAT	NULL
proteins	NULL
binding	NULL
to	NULL
P	NULL
elements	NULL
are	NULL
essential	NULL
for	NULL
IL-4	NULL
promoter	NULL
activity	NULL
by	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
generated	NULL
an	NULL
expression	NULL
construct	NULL
for	NULL
an	NULL
amino-terminal-truncated	NULL
form	NULL
of	NULL
NFAT1	NULL
(	NULL
NFATIANH/pREP-4	NULL
)	NULL
.	NULL

This	NULL
truncated	NULL
form	NULL
of	NULL
NFAT1	NULL
should	NULL
act	NULL
as	NULL
a	NULL
dominant-negative	NULL
since	NULL
it	NULL
lacks	NULL
a	NULL
region	NULL
containing	NULL
an	NULL
important	NULL
transcriptional	NULL
activation	NULL
domain	NULL
,	NULL
while	NULL
retaining	NULL
the	NULL
domain	NULL
required	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
P	NULL
element	NULL
(	NULL
64	NULL
)	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
cotransfection	NULL
of	NULL
this	NULL
construct	NULL
into	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
substantially	NULL
decreased	NULL
pIL-4-Luc	NULL
activity	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
full-length	NULL
NFAT1	NULL
plasmid	NULL
,	NULL
which	NULL
slightly	NULL
enhanced	NULL
luciferase	NULL
production	NULL
.	NULL

The	NULL
NFATIANH	NULL
,	NULL
/pREP-4	NULL
inhibitory	NULL
activity	NULL
was	NULL
specific	NULL
,	NULL
in	NULL
that	NULL
it	NULL
did	NULL
not	NULL
inhibit	NULL
a	NULL
reporter	NULL
plasmid	NULL
(	NULL
pCMV-Luc	NULL
)	NULL
lacking	NULL
P	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
NFAT	NULL
proteins	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
by	NULL
primed	NULL
T	NULL
cells	NULL
.	NULL

Although	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
NFAT	NULL
protein	NULL
bound	NULL
to	NULL
the	NULL
IL-4	NULL
P1	NULL
element	NULL
in	NULL
vitro	NULL
appeared	NULL
to	NULL
be	NULL
NFAT1	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
and	NULL
because	NULL
NFAT2	NULL
and	NULL
NFAT4	NULL
have	NULL
been	NULL
detected	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
(	NULL
17	NULL
,	NULL
42	NULL
,	NULL
61	NULL
)	NULL
,	NULL
it	NULL
remained	NULL
formally	NULL
possible	NULL
that	NULL
either	NULL
NFAT2	NULL
or	NULL
NFAT4	NULL
was	NULL
contributing	NULL
to	NULL
the	NULL
increased	NULL
IL-4	NULL
gene	NULL
transcription	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
address	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
analyzed	NULL
nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
freshly	NULL
isolated	NULL
and	NULL
in	NULL
vitro-primed	NULL
human	NULL
peripheral	NULL
blood	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
before	NULL
and	NULL
after	NULL
polyclonal	NULL
activation	NULL
in	NULL
vitro	NULL
,	NULL
for	NULL
NFAT2	NULL
and	NULL
NFAT4	NULL
expression	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

It	NULL
was	NULL
first	NULL
confirmed	NULL
that	NULL
NFAT1	NULL
was	NULL
markedly	NULL
increased	NULL
in	NULL
€D4	NULL
T	NULL
cells	NULL
by	NULL
in	NULL
vitro	NULL
priming	NULL
,	NULL
as	NULL
detected	NULL
by	NULL
an	NULL
NFAT	NULL
1-specific	NULL
mAb	NULL
directed	NULL
against	NULL
a	NULL
unique	NULL
epitope	NULL
from	NULL
the	NULL
antisera	NULL
used	NULL
in	NULL
Fig	NULL
.	NULL

4D	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
NFAT2	NULL
levels	NULL
appeared	NULL
to	NULL
be	NULL
decreased	NULL
in	NULL
the	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
NFAT4	NULL
also	NULL
appeared	NULL
to	NULL
be	NULL
increased	NULL
with	NULL
priming	NULL
,	NULL
although	NULL
to	NULL
a	NULL
lesser	NULL
degree	NULL
than	NULL
NFAT1	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
these	NULL
results	NULL
,	NULL
freshly	NULL
isolated	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
pIL-4-Luc	NULL
reporter	NULL
gene	NULL
and	NULL
cotransfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
pREP-4	NULL
control	NULL
,	NULL
NFAT2/pREP-4	NULL
,	NULL
or	NULL
NFATA4/pREP-4	NULL
expression	NULL
vectors	NULL
.	NULL

Like	NULL
NFAT1/pREP-4	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
,	NULL
NFAT2/pREP-4	NULL
was	NULL
able	NULL
to	NULL
substantially	NULL
(	NULL
~4.5-fold	NULL
)	NULL
augment	NULL
IL-4	NULL
promoter-directed	NULL
transcription	NULL
in	NULL
freshly	NULL
isolated	NULL
CD4	NULL
T	NULL
cells	NULL
relative	NULL
to	NULL
the	NULL
pREP-4	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
NFAT4/pREP-4	NULL
was	NULL
consistently	NULL
unable	NULL
to	NULL
augment	NULL
IL-4	NULL
promoter-directed	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
,	NULL
while	NULL
capable	NULL
of	NULL
increasing	NULL
IL-2	NULL
promoter-directed	NULL
transcription	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
may	NULL
reflect	NULL
the	NULL
reported	NULL
poor	NULL
binding	NULL
of	NULL
NFAT4	NULL
to	NULL
the	NULL
IL-4	NULL
P1	NULL
element	NULL
in	NULL
vitro	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Since	NULL
NFAT2	NULL
can	NULL
be	NULL
substantially	NULL
increased	NULL
in	NULL
response	NULL
to	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
this	NULL
protein	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
augmenting	NULL
IL-4	NULL
transcription	NULL
after	NULL
NFAT1	NULL
acts	NULL
initially	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
as	NULL
if	NULL
NFAT1	NULL
is	NULL
largely	NULL
responsible	NULL
for	NULL
the	NULL
initial	NULL
NFAT-dependent	NULL
increase	NULL
in	NULL
IL-4	NULL
expression	NULL
by	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
from	NULL
peripheral	NULL
blood	NULL
.	NULL

NFAT1	NULL
867	NULL
B.	NULL
C.	NULL
+	NULL
oo+	NULL
-o-	NULL
og	NULL
+	NULL
Se	NULL
e	NULL
a	NULL
Pro	NULL
Fro	NULL
Pr	NULL
Fro	NULL
Pro	NULL
Fr	NULL
Pr	NULL
Fro	NULL
Pro	NULL
Fro	NULL
Pr	NULL
kDa	NULL
kDa	NULL
250-	NULL
250	NULL
160-	NULL
160	NULL
105-	NULL
o	NULL
105-T5-	NULL
-	NULL
75-	NULL
``	NULL
=	NULL
50-	NULL
50	NULL
-25-	NULL
25-NFAT2	NULL
NFAT4	NULL
Discussion	NULL
The	NULL
IL-4	NULL
gene	NULL
serves	NULL
as	NULL
a	NULL
useful	NULL
model	NULL
for	NULL
the	NULL
alterations	NULL
in	NULL
cytokine	NULL
gene	NULL
expression	NULL
during	NULL
extrathymic	NULL
T	NULL
cell	NULL
differentiation	NULL
,	NULL
since	NULL
its	NULL
expression	NULL
by	NULL
T	NULL
cells	NULL
is	NULL
dramatically	NULL
increased	NULL
by	NULL
priming	NULL
both	NULL
in	NULL
vitro	NULL
(	NULL
8	NULL
)	NULL
and	NULL
in	NULL
vivo	NULL
(	NULL
65	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
events	NULL
leading	NULL
to	NULL
increased	NULL
IL-4	NULL
production	NULL
by	NULL
T	NULL
cell	NULL
priming	NULL
are	NULL
of	NULL
considerable	NULL
interest	NULL
,	NULL
since	NULL
IL-4	NULL
potentially	NULL
regulates	NULL
the	NULL
outcome	NULL
of	NULL
the	NULL
effector	NULL
T	NULL
cell	NULL
immune	NULL
response	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
promote	NULL
Th2	NULL
differentiation	NULL
and	NULL
inhibit	NULL
Th1	NULL
differentiation	NULL
(	NULL
reviewed	NULL
by	NULL
Abbas	NULL
et	NULL
al	NULL
.	NULL

in	NULL
Ref	NULL
.	NULL

66	NULL
)	NULL
.	NULL

The	NULL
acquisition	NULL
of	NULL
an	NULL
enhanced	NULL
ability	NULL
for	NULL
cytokine	NULL
gene	NULL
transcription	NULL
and	NULL
production	NULL
during	NULL
T	NULL
cell	NULL
priming	NULL
is	NULL
critical	NULL
for	NULL
normal	NULL
effector	NULL
T	NULL
cell	NULL
function	NULL
,	NULL
although	NULL
the	NULL
mechanisms	NULL
underlying	NULL
this	NULL
are	NULL
poorly	NULL
understood	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
focused	NULL
on	NULL
defining	NULL
how	NULL
priming	NULL
increases	NULL
IL-4	NULL
expression	NULL
by	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
comparing	NULL
molecular	NULL
events	NULL
involved	NULL
in	NULL
IL-4	NULL
gene	NULL
transcription	NULL
in	NULL
freshly	NULL
isolated	NULL
peripheral	NULL
blood	NULL
CD4	NULL
T	NULL
cells	NULL
with	NULL
those	NULL
occurring	NULL
when	NULL
these	NULL
cells	NULL
have	NULL
been	NULL
primed	NULL
in	NULL
vitro	NULL
.	NULL

We	NULL
determined	NULL
that	NULL
the	NULL
IL-4	NULL
gene	NULL
5	NULL
'	NULL
flank	NULL
promoter	NULL
segment	NULL
was	NULL
significantly	NULL
more	NULL
active	NULL
in	NULL
primed	NULL
than	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
proximal	NULL
human	NULL
IL-2	NULL
gene	NULL
promoter	NULL
was	NULL
equally	NULL
active	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
vivo	NULL
footprint	NULL
analysis	NULL
of	NULL
the	NULL
proximal	NULL
IL-4	NULL
promoter	NULL
demonstrated	NULL
activation-dependent	NULL
engagement	NULL
of	NULL
the	NULL
two	NULL
most	NULL
proximal	NULL
NFAT	NULL
-binding	NULL
sites	NULL
in	NULL
primed	NULL
but	NULL
not	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
contained	NULL
more	NULL
NFAT1	NULL
and	NULL
directed	NULL
more	NULL
NFAT	NULL
-driven	NULL
transcription	NULL
than	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
exogenous	NULL
NFAT1	NULL
,	NULL
achieved	NULL
via	NULL
transfection	NULL
of	NULL
expression	NULL
plasmids	NULL
,	NULL
dramatically	NULL
enhanced	NULL
IL-A-mediated	NULL
transcription	NULL
by	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
only	NULL
modestly	NULL
augmented	NULL
IL-4	NULL
transcription	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
demonstrated	NULL
that	NULL
NFAT1	NULL
levels	NULL
were	NULL
limiting	NULL
for	NULL
IL-4	NULL
transcription	NULL
by	NULL
fresh	NULL
€D4	NULL
T	NULL
cells	NULL
but	NULL
adequate	NULL
for	NULL
IL-4	NULL
transcription	NULL
by	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
cellular	NULL
NFAT	NULL
levels	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
powerful	NULL
,	NULL
yet	NULL
elegantly	NULL
simple	NULL
,	NULL
mechanism	NULL
by	NULL
which	NULL
to	NULL
control	NULL
the	NULL
selective	NULL
ability	NULL
of	NULL
primed/effector	NULL
€D4	NULL
T	NULL
cells	NULL
to	NULL
transcribe	NULL
IL-4	NULL
and	NULL
probably	NULL
most	NULL
other	NULL
T	NULL
cell-derived	NULL
cytokines	NULL
whose	NULL
promoters	NULL
possess	NULL
NFAT-binding	NULL
cis-elements	NULL
.	NULL

The	NULL
notable	NULL
exception	NULL
to	NULL
this	NULL
dictum	NULL
is	NULL
IL-2	NULL
.	NULL

The	NULL
IL-2	NULL
promoter	NULL
appears	NULL
to	NULL
be	NULL
less	NULL
selective	NULL
in	NULL
which	NULL
NFAT	NULL
proteins	NULL
it	NULL
can	NULL
bind	NULL
,	NULL
allowing	NULL
for	NULL
transcription	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
NFAT1	NULL
in	NULL
freshly	NULL
isolated	NULL
T	NULL
cells	NULL
may	NULL
have	NULL
little	NULL
to	NULL
no	NULL
effect	NULL
on	NULL
IL-2	NULL
production	NULL
,	NULL
if	NULL
,	NULL
for	NULL
example	NULL
,	NULL
NFAT2	NULL
or	NULL
NFAT4	NULL
is	NULL
available	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
IL-2	NULL
promoter	NULL
may	NULL
rely	NULL
more	NULL
on	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
for	NULL
activation-dependent	NULL
transcription	NULL
(	NULL
67	NULL
,	NULL
68	NULL
)	NULL
,	NULL
while	NULL
these	NULL
same	NULL
factors	NULL
in	NULL
the	NULL
same	NULL
cellular	NULL
context	NULL
may	NULL
actually	NULL
inhibit	NULL
IL-4	NULL
promoter	NULL
activity	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
IL-2	NULL
promoter	NULL
may	NULL
simply	NULL
require	NULL
lower	NULL
levels	NULL
of	NULL
NFAT	NULL
for	NULL
binding	NULL
and	NULL
transactivation	NULL
than	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
868	NULL
Previously	NULL
,	NULL
sites	NULL
of	NULL
DNA-protein	NULL
interactions	NULL
involved	NULL
in	NULL
transcription	NULL
of	NULL
the	NULL
proximal	NULL
IL-2	NULL
promoter	NULL
have	NULL
been	NULL
examined	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
(	NULL
23	NULL
,	NULL
70	NULL
)	NULL
.	NULL

However	NULL
,	NULL
to	NULL
the	NULL
best	NULL
of	NULL
our	NULL
knowledge	NULL
,	NULL
no	NULL
in	NULL
vivo	NULL
footprinting	NULL
of	NULL
cytokine	NULL
promoters	NULL
has	NULL
been	NULL
performed	NULL
with	NULL
nontransformed	NULL
T	NULL
cells	NULL
,	NULL
nor	NULL
has	NULL
there	NULL
been	NULL
any	NULL
previous	NULL
reports	NULL
of	NULL
in	NULL
vivo	NULL
footprinting	NULL
analysis	NULL
of	NULL
the	NULL
proximal	NULL
IL-4	NULL
promoter	NULL
.	NULL

Our	NULL
in	NULL
vivo	NULL
footprinting	NULL
analysis	NULL
of	NULL
the	NULL
two	NULL
P	NULL
elements	NULL
closest	NULL
to	NULL
the	NULL
IL-4	NULL
TSS	NULL
,	NULL
PO	NULL
and	NULL
P1	NULL
,	NULL
revealed	NULL
that	NULL
after	NULL
polyclonal	NULL
activation	NULL
both	NULL
sites	NULL
were	NULL
clearly	NULL
engaged	NULL
in	NULL
the	NULL
primed	NULL
CD4	NULL
T	NULL
cell	NULL
population	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
DNA	NULL
residues	NULL
found	NULL
to	NULL
interact	NULL
with	NULL
NFAT	NULL
based	NULL
on	NULL
the	NULL
recently	NULL
derived	NULL
solution	NULL
(	NULL
NFAT2	NULL
)	NULL
(	NULL
71	NULL
,	NULL
72	NULL
)	NULL
and	NULL
crystal	NULL
(	NULL
NFAT1	NULL
)	NULL
(	NULL
73	NULL
)	NULL
structures	NULL
of	NULL
NFAT	NULL
,	NULL
we	NULL
found	NULL
the	NULL
identical	NULL
three	NULL
purine	NULL
residues	NULL
(	NULL
GGA	NULL
)	NULL
of	NULL
the	NULL
PO	NULL
and	NULL
P1	NULL
elements	NULL
were	NULL
most	NULL
consistently	NULL
footprinted	NULL
after	NULL
activation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
both	NULL
PO	NULL
and	NULL
P1	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
independently	NULL
critical	NULL
for	NULL
optimal	NULL
IL-4	NULL
promoter	NULL
activity	NULL
by	NULL
reporter	NULL
gene	NULL
analysis	NULL
,	NULL
similar	NULL
to	NULL
what	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
for	NULL
proximal	NULL
P	NULL
elements	NULL
of	NULL
the	NULL
human	NULL
CD4O-ligand	NULL
promoter	NULL
(	NULL
27	NULL
)	NULL
and	NULL
for	NULL
corresponding	NULL
sites	NULL
in	NULL
the	NULL
murine	NULL
IL-4	NULL
promoter	NULL
(	NULL
74	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
engagement	NULL
of	NULL
the	NULL
two	NULL
most	NULL
proximal	NULL
NFAT-binding	NULL
P	NULL
elements	NULL
is	NULL
critical	NULL
for	NULL
,	NULL
and	NULL
correlates	NULL
with	NULL
,	NULL
IL-4	NULL
gene	NULL
transcription	NULL
by	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
P1	NULL
element	NULL
in	NULL
IL-4	NULL
gene	NULL
expression	NULL
by	NULL
effector	NULL
T	NULL
cells	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
recent	NULL
murine	NULL
experiments	NULL
in	NULL
which	NULL
a	NULL
P1	NULL
multimer-driven	NULL
reporter	NULL
transgene	NULL
was	NULL
active	NULL
in	NULL
effector	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
freshly	NULL
isolated	NULL
T	NULL
cells	NULL
(	NULL
75	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
found	NULL
the	NULL
bulk	NULL
of	NULL
NFAT	NULL
protein	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
capable	NULL
of	NULL
binding	NULL
P	NULL
elements	NULL
was	NULL
NFAT1	NULL
(	NULL
17	NULL
,	NULL
20	NULL
,	NULL
27	NULL
,	NULL
42	NULL
)	NULL
and	NULL
the	NULL
remainder	NULL
was	NULL
NFAT2	NULL
(	NULL
41	NULL
,	NULL
42	NULL
,	NULL
76	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
these	NULL
results	NULL
,	NULL
supershift	NULL
assays	NULL
using	NULL
the	NULL
IL-4	NULL
P1	NULL
element	NULL
oligonucleotide	NULL
indicated	NULL
that	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
the	NULL
complex	NULL
formed	NULL
with	NULL
nuclear	NULL
protein	NULL
from	NULL
fresh	NULL
or	NULL
primed	NULL
T	NULL
cells	NULL
contained	NULL
NFAT1	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Since	NULL
NFAT	NULL
proteins	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
DNA	NULL
in	NULL
vitro	NULL
as	NULL
monomers	NULL
(	NULL
14	NULL
,	NULL
72	NULL
,	NULL
73	NULL
)	NULL
,	NULL
this	NULL
suggested	NULL
that	NULL
NFAT1	NULL
was	NULL
the	NULL
predominant	NULL
NFAT	NULL
species	NULL
involved	NULL
in	NULL
binding	NULL
to	NULL
the	NULL
proximal	NULL
IL-4	NULL
P	NULL
elements	NULL
in	NULL
vitro	NULL
and	NULL
,	NULL
by	NULL
inference	NULL
,	NULL
in	NULL
vivo	NULL
.	NULL

Moreover	NULL
,	NULL
primed	NULL
T	NULL
cells	NULL
clearly	NULL
possessed	NULL
more	NULL
protein	NULL
binding	NULL
activity	NULL
for	NULL
the	NULL
IL-4	NULL
P1	NULL
element	NULL
than	NULL
did	NULL
fresh	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
both	NULL
cell	NULL
populations	NULL
had	NULL
similar	NULL
amounts	NULL
of	NULL
AP-1	NULL
protein	NULL
binding	NULL
activity	NULL
.	NULL

This	NULL
quantitative	NULL
difference	NULL
in	NULL
NFAT1	NULL
may	NULL
account	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
detect	NULL
in	NULL
vivo	NULL
footprints	NULL
of	NULL
the	NULL
proximal	NULL
P	NULL
elements	NULL
in	NULL
primed	NULL
but	NULL
not	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
quantitative	NULL
differences	NULL
in	NULL
nuclear	NULL
NFAT1	NULL
protein	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
,	NULL
qualitative	NULL
differences	NULL
were	NULL
noted	NULL
between	NULL
nuclear	NULL
NFAT1	NULL
protein	NULL
from	NULL
fresh	NULL
and	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
such	NULL
that	NULL
a	NULL
significant	NULL
portion	NULL
of	NULL
the	NULL
nuclear	NULL
NFAT1	NULL
from	NULL
the	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
migrated	NULL
at	NULL
an	NULL
apparent	NULL
lower	NULL
m.w	NULL
.	NULL

Others	NULL
have	NULL
shown	NULL
that	NULL
lower	NULL
m.w	NULL
.	NULL

forms	NULL
of	NULL
NFAT	NULL
detected	NULL
after	NULL
activation	NULL
represent	NULL
less	NULL
phosphorylated	NULL
proteins	NULL
(	NULL
19	NULL
,	NULL
62	NULL
)	NULL
.	NULL

The	NULL
lower	NULL
m.w	NULL
.	NULL

NFAT1	NULL
protein	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
most	NULL
likely	NULL
reflects	NULL
a	NULL
requirement	NULL
for	NULL
dephosphorylation	NULL
of	NULL
NFAT1	NULL
for	NULL
its	NULL
nuclear	NULL
translocation	NULL
and	NULL
frans-activation	NULL
,	NULL
similar	NULL
to	NULL
NFAT4	NULL
(	NULL
19	NULL
)	NULL
.	NULL

A	NULL
requirement	NULL
for	NULL
dephosphorylation	NULL
may	NULL
also	NULL
explain	NULL
the	NULL
lack	NULL
of	NULL
in	NULL
vivo	NULL
footprints	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
before	NULL
activation	NULL
when	NULL
higher	NULL
m.w	NULL
.	NULL

NFAT	NULL
proteins	NULL
are	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
NFAT	NULL
proteins	NULL
in	NULL
the	NULL
nucleus	NULL
before	NULL
activation	NULL
has	NULL
also	NULL
recently	NULL
been	NULL
observed	NULL
in	NULL
murine	NULL
T	NULL
cells	NULL
following	NULL
priming	NULL
with	NULL
mitogen	NULL
and	NULL
exogenous	NULL
IL-4	NULL
(	NULL
60	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
observation	NULL
is	NULL
not	NULL
unique	NULL
to	NULL
human	NULL
T	NULL
cells	NULL
or	NULL
the	NULL
particular	NULL
priming	NULL
conditions	NULL
we	NULL
employed	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
NFAT	NULL
in	NULL
the	NULL
nucleus	NULL
most	NULL
likely	NULL
reflects	NULL
a	NULL
balance	NULL
between	NULL
the	NULL
phosphatase	NULL
activity	NULL
of	NULL
calcineurin	NULL
and	NULL
nuclear	NULL
kinases	NULL
which	NULL
enhance	NULL
nuclear	NULL
export	NULL
of	NULL
NFAT	NULL
(	NULL
19	NULL
,	NULL
77	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
although	NULL
priming	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
results	NULL
in	NULL
quantitative	NULL
differences	NULL
in	NULL
NFAT	NULL
,	NULL
qualitative	NULL
alter	NULL
NFAT	NULL
ENHANCES	NULL
IL-4	NULL
IN	NULL
PRIMED	NULL
CD4	NULL
T	NULL
CELLS	NULL
ations	NULL
in	NULL
NFAT	NULL
may	NULL
also	NULL
be	NULL
required	NULL
for	NULL
NFAT	NULL
to	NULL
bind	NULL
to	NULL
,	NULL
and	NULL
promote	NULL
transcription	NULL
of	NULL
,	NULL
the	NULL
IL-4	NULL
promoter	NULL
and	NULL
gene	NULL
,	NULL
respectively	NULL
.	NULL

Wild-type	NULL
NFAT	NULL
protein	NULL
appears	NULL
critical	NULL
for	NULL
optimal	NULL
IL-4	NULL
transcription	NULL
by	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
that	NULL
expression	NULL
of	NULL
a	NULL
form	NULL
of	NULL
NFAT1	NULL
lacking	NULL
the	NULL
amino-terminal	NULL
frans-activation	NULL
domain	NULL
decreased	NULL
IL-4	NULL
promoter	NULL
activity	NULL
.	NULL

Since	NULL
this	NULL
truncated	NULL
NFAT1	NULL
protein	NULL
retained	NULL
its	NULL
central	NULL
DNA-binding	NULL
domain	NULL
(	NULL
64	NULL
)	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
this	NULL
protein	NULL
interfered	NULL
with	NULL
IL-4	NULL
promoter	NULL
activity	NULL
by	NULL
competing	NULL
for	NULL
binding	NULL
to	NULL
P	NULL
elements	NULL
,	NULL
although	NULL
its	NULL
involvement	NULL
at	NULL
other	NULL
steps	NULL
of	NULL
NFAT	NULL
activation	NULL
and/or	NULL
nuclear	NULL
translocation	NULL
can	NULL
not	NULL
be	NULL
ex-cluded	NULL
.	NULL

Thus	NULL
,	NULL
binding	NULL
of	NULL
wild-type	NULL
NFAT	NULL
protein	NULL
to	NULL
the	NULL
proximal	NULL
P	NULL
elements	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
contributes	NULL
to	NULL
the	NULL
ability	NULL
of	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
to	NULL
transcribe	NULL
IL-4	NULL
mRNA	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
priming	NULL
acts	NULL
to	NULL
increase	NULL
IL-4	NULL
gene	NULL
transcription	NULL
by	NULL
a	NULL
NFAT-dependent	NULL
mechanism	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
clearly	NULL
show	NULL
that	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
are	NULL
relatively	NULL
deficient	NULL
in	NULL
nuclear	NULL
NFAT	NULL
proteins	NULL
after	NULL
activation	NULL
,	NULL
and	NULL
that	NULL
this	NULL
cell	NULL
type	NULL
's	NULL
limited	NULL
ability	NULL
for	NULL
IL-4	NULL
promoter-directed	NULL
transcription	NULL
can	NULL
be	NULL
overcome	NULL
by	NULL
increased	NULL
amounts	NULL
of	NULL
wild-type	NULL
NFAT1	NULL
protein	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
NFAT1	NULL
may	NULL
be	NULL
critical	NULL
for	NULL
limiting	NULL
expression	NULL
of	NULL
certain	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-4	NULL
,	NULL
to	NULL
effector	NULL
or	NULL
memory	NULL
T	NULL
cell	NULL
populations	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
there	NULL
may	NULL
be	NULL
a	NULL
threshold	NULL
level	NULL
of	NULL
NFAT1	NULL
,	NULL
lacking	NULL
in	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
but	NULL
present	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
that	NULL
is	NULL
required	NULL
for	NULL
NFAT	NULL
binding	NULL
to	NULL
the	NULL
proximal	NULL
P	NULL
elements	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
to	NULL
initiate	NULL
transcription	NULL
.	NULL

If	NULL
NFAT	NULL
binding	NULL
to	NULL
P	NULL
elements	NULL
is	NULL
competed	NULL
by	NULL
binding	NULL
of	NULL
neighboring	NULL
inhibitory	NULL
factors	NULL
in	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
then	NULL
a	NULL
greater	NULL
level	NULL
of	NULL
nuclear	NULL
NFAT	NULL
might	NULL
be	NULL
required	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
for	NULL
sustained	NULL
binding	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
scaffolding	NULL
proteins	NULL
,	NULL
or	NULL
modifiers	NULL
of	NULL
transcription	NULL
factors	NULL
or	NULL
chromatin	NULL
accessibility	NULL
may	NULL
also	NULL
be	NULL
required	NULL
for	NULL
P	NULL
element	NULL
binding	NULL
by	NULL
NFAT	NULL
to	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

These	NULL
proteins	NULL
might	NULL
be	NULL
lacking	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
and	NULL
might	NULL
be	NULL
preferentially	NULL
increased	NULL
in	NULL
their	NULL
activity	NULL
or	NULL
abundance	NULL
by	NULL
priming	NULL
.	NULL

The	NULL
recently	NULL
identified	NULL
NFAT-interacting	NULL
protein	NULL
(	NULL
NIP45	NULL
)	NULL
(	NULL
78	NULL
)	NULL
or	NULL
GATA-3	NULL
(	NULL
79	NULL
)	NULL
may	NULL
be	NULL
such	NULL
proteins	NULL
.	NULL

Recently	NULL
,	NULL
three	NULL
laboratories	NULL
have	NULL
independently	NULL
generated	NULL
mice	NULL
that	NULL
lack	NULL
NFAT1	NULL
as	NULL
a	NULL
result	NULL
of	NULL
selective	NULL
gene	NULL
disruption	NULL
(	NULL
80-82	NULL
)	NULL
,	NULL
but	NULL
the	NULL
effect	NULL
of	NULL
this	NULL
complete	NULL
NFAT1	NULL
deficiency	NULL
on	NULL
memory	NULL
and	NULL
effector	NULL
T	NULL
cell	NULL
development	NULL
has	NULL
not	NULL
been	NULL
well	NULL
characterized	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
cytokines	NULL
by	NULL
T	NULL
cells	NULL
from	NULL
two	NULL
of	NULL
these	NULL
lines	NULL
is	NULL
reminiscent	NULL
of	NULL
the	NULL
cytokine	NULL
profile	NULL
of	NULL
fresh	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
NFATI	NULL
'~	NULL
mice	NULL
challenged	NULL
in	NULL
vivo	NULL
with	NULL
a	NULL
polyclonal	NULL
stimulus	NULL
(	NULL
anti-CD3e	NULL
mAb	NULL
)	NULL
,	NULL
the	NULL
T	NULL
cells	NULL
demonstrated	NULL
early	NULL
defective	NULL
mRNA	NULL
production	NULL
of	NULL
most	NULL
all	NULL
T	NULL
cell-derived	NULL
cytokines	NULL
,	NULL
except	NULL
IL-2	NULL
(	NULL
80	NULL
)	NULL
,	NULL
and	NULL
in	NULL
similar	NULL
NFATI	NULL
'~	NULL
mice	NULL
,	NULL
splenocytes	NULL
polyclonally	NULL
activated	NULL
in	NULL
vitro	NULL
for	NULL
up	NULL
to	NULL
2	NULL
days	NULL
also	NULL
demonstrated	NULL
substantial	NULL
defects	NULL
in	NULL
most	NULL
cytokine	NULL
mRNA	NULL
while	NULL
expressing	NULL
normal	NULL
levels	NULL
of	NULL
IL-2	NULL
message	NULL
(	NULL
82	NULL
)	NULL
.	NULL

This	NULL
included	NULL
the	NULL
almost	NULL
complete	NULL
loss	NULL
of	NULL
transcripts	NULL
for	NULL
IL-4	NULL
,	NULL
as	NULL
well	NULL
as	NULL
substantial	NULL
reductions	NULL
in	NULL
IL-5	NULL
,	NULL
IL-13	NULL
,	NULL
GM-CSF	NULL
,	NULL
TNF-a	NULL
,	NULL
CD40-ligand	NULL
,	NULL
and	NULL
Fas-ligand	NULL
mRNA	NULL
(	NULL
80	NULL
,	NULL
82	NULL
)	NULL
.	NULL

These	NULL
cytokine	NULL
genes	NULL
contain	NULL
one	NULL
or	NULL
more	NULL
NFAT	NULL
binding	NULL
sites	NULL
within	NULL
their	NULL
en-hancers	NULL
or	NULL
5	NULL
'	NULL
flank	NULL
promoters	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
,	NULL
in	NULL
most	NULL
cases	NULL
,	NULL
expression	NULL
of	NULL
these	NULL
cytokines	NULL
is	NULL
increased	NULL
by	NULL
T	NULL
cell	NULL
priming	NULL
(	NULL
8	NULL
,	NULL
9	NULL
,	NULL
20	NULL
,	NULL
83	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-2	NULL
transcript	NULL
levels	NULL
were	NULL
only	NULL
minimally	NULL
reduced	NULL
(	NULL
80	NULL
,	NULL
82	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
NFAT1	NULL
is	NULL
limiting	NULL
for	NULL
most	NULL
early	NULL
cytokine	NULL
gene	NULL
expression	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
IL-2	NULL
.	NULL

However	NULL
,	NULL
IL-4	NULL
gene	NULL
transcription	NULL
by	NULL
polyclonally	NULL
activated	NULL
primary	NULL
T	NULL
cells	NULL
was	NULL
reported	NULL
to	NULL
be	NULL
unaffected	NULL
early	NULL
in	NULL
a	NULL
third	NULL
set	NULL
of	NULL
NFATI	NULL
'~	NULL
mice	NULL
,	NULL
and	NULL
actually	NULL
increased	NULL
at	NULL
later	NULL
time	NULL
points	NULL
(	NULL
81	NULL
,	NULL
84	NULL
)	NULL
.	NULL

It	NULL
remains	NULL
unclear	NULL
whether	NULL
these	NULL
markedly	NULL
different	NULL
results	NULL
are	NULL
attributable	NULL
to	NULL
differences	NULL
in	NULL
experimental	NULL
design	NULL
,	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
gene	NULL
disruption	NULL
used	NULL
and	NULL
its	NULL
effects	NULL
on	NULL
intrathymic	NULL
or	NULL
extrathymic	NULL
T	NULL
cell	NULL
maturation	NULL
,	NULL
or	NULL
differences	NULL
in	NULL
compensatory	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
mechanisms	NULL
for	NULL
cytokine	NULL
gene	NULL
transcription	NULL
among	NULL
the	NULL
three	NULL
different	NULL
knockout	NULL
strains	NULL
.	NULL

Clearly	NULL
,	NULL
under	NULL
conditions	NULL
of	NULL
chronic	NULL
stimulation	NULL
,	NULL
such	NULL
as	NULL
allergic	NULL
challenge	NULL
,	NULL
NFAT1	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
high	NULL
levels	NULL
of	NULL
IL-4	NULL
production	NULL
in	NULL
vivo	NULL
(	NULL
81	NULL
,	NULL
85	NULL
)	NULL
.	NULL

However	NULL
,	NULL
all	NULL
three	NULL
independently	NULL
generated	NULL
NFATI	NULL
'~	NULL
mouse	NULL
strains	NULL
have	NULL
evidence	NULL
of	NULL
abnormally	NULL
increased	NULL
accumulation	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
with	NULL
age	NULL
(	NULL
80-82	NULL
)	NULL
,	NULL
and	NULL
,	NULL
in	NULL
at	NULL
least	NULL
one	NULL
strain	NULL
,	NULL
increased	NULL
expression	NULL
of	NULL
cell	NULL
surface	NULL
activation	NULL
markers	NULL
(	NULL
86	NULL
)	NULL
.	NULL

This	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
T	NULL
cell	NULL
homeostasis	NULL
is	NULL
altered	NULL
in	NULL
these	NULL
animals	NULL
,	NULL
perhaps	NULL
due	NULL
to	NULL
the	NULL
decreased	NULL
expression	NULL
of	NULL
Fas-ligand	NULL
(	NULL
80	NULL
)	NULL
by	NULL
NFATI	NULL
'~	NULL
T	NULL
cells	NULL
.	NULL

Decreased	NULL
fas-ligand	NULL
or	NULL
other	NULL
alterations	NULL
leading	NULL
to	NULL
decreased	NULL
apoptosis	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
vivo	NULL
(	NULL
86	NULL
)	NULL
might	NULL
perturb	NULL
their	NULL
priming	NULL
for	NULL
increased	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

These	NULL
results	NULL
can	NULL
be	NULL
reconciled	NULL
with	NULL
our	NULL
data	NULL
with	NULL
human	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
assuming	NULL
that	NULL
NFAT1	NULL
has	NULL
an	NULL
early	NULL
important	NULL
role	NULL
in	NULL
the	NULL
initiation	NULL
of	NULL
IL-4	NULL
gene	NULL
transcription	NULL
and	NULL
a	NULL
later	NULL
role	NULL
that	NULL
directly	NULL
or	NULL
indirectly	NULL
inhibits	NULL
Th2	NULL
development	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
priming	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
increases	NULL
IL-4	NULL
promoter-directed	NULL
transcription	NULL
,	NULL
and	NULL
significantly	NULL
increases	NULL
NFAT1	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
proximal	NULL
P	NULL
elements	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
in	NULL
vivo	NULL
.	NULL

Addition	NULL
of	NULL
exogenous	NULL
wild-type	NULL
NFAT1	NULL
can	NULL
partially	NULL
overcome	NULL
the	NULL
comparative	NULL
defect	NULL
in	NULL
IL-4	NULL
production	NULL
by	NULL
unprimed	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
relatively	NULL
NFAT	NULL
Furthermore	NULL
,	NULL
dominant-negative	NULL
experiments	NULL
show	NULL
the	NULL
importance	NULL
of	NULL
wild-type	NULL
NFAT	NULL
for	NULL
optimal	NULL
IL-4	NULL
transcription	NULL
in	NULL
primed	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Lastly	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
reveals	NULL
that	NULL
priming	NULL
increases	NULL
NFAT1	NULL
and	NULL
NFAT4	NULL
,	NULL
but	NULL
not	NULL
NFAT2	NULL
,	NULL
levels	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
NFAT4	NULL
does	NULL
not	NULL
appear	NULL
capable	NULL
of	NULL
substantially	NULL
increasing	NULL
IL-4	NULL
promoter-directed	NULL
gene	NULL
transcription	NULL
in	NULL
normal	NULL
human	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Together	NULL
with	NULL
the	NULL
results	NULL
observed	NULL
in	NULL
NFATI	NULL
'~	NULL
mice	NULL
(	NULL
80	NULL
,	NULL
82	NULL
)	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
NFAT1	NULL
with	NULL
priming	NULL
may	NULL
not	NULL
only	NULL
contribute	NULL
to	NULL
increased	NULL
IL-4	NULL
production	NULL
,	NULL
but	NULL
may	NULL
also	NULL
contribute	NULL
globally	NULL
to	NULL
the	NULL
enhanced	NULL
production	NULL
of	NULL
most	NULL
T	NULL
cell-derived	NULL
cytokines	NULL
by	NULL
effector	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
David	NULL
Coder	NULL
and	NULL
Kathryn	NULL
Allen	NULL
for	NULL
help	NULL
with	NULL
FCF	NULL
;	NULL
Dr.	NULL
Seymour	NULL
Klebanoff	NULL
(	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
for	NULL
help	NULL
with	NULL
luminometer	NULL
measurements	NULL
;	NULL
Dr.	NULL
Chris	NULL
Hughes	NULL
(	NULL
University	NULL
of	NULL
California	NULL
at	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
the	NULL
electroporation	NULL
protocol	NULL
;	NULL
Dr.	NULL
Calman	NULL
Prussin	NULL
(	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Disease	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
for	NULL
the	NULL
intracellular	NULL
cytokine	NULL
staining	NULL
protocol	NULL
;	NULL
Drs	NULL
.	NULL

Anjana	NULL
Rao	NULL
(	NULL
Center	NULL
for	NULL
Blood	NULL
Research	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
Timothy	NULL
Hoey	NULL
(	NULL
Tularik	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
Kenneth	NULL
Murphy	NULL
(	NULL
Washington	NULL
University	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
Charles	NULL
Zacharchuk	NULL
(	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
Marianne	NULL
Sweetser	NULL
(	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
,	NULL
Luika	NULL
Timmerman	NULL
,	NULL
Gerald	NULL
Crabtree	NULL
(	NULL
Stanford	NULL
University	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
Ken	NULL
Grabstein	NULL
(	NULL
Immunex	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
for	NULL
providing	NULL
reagents	NULL
;	NULL
Lisa	NULL
Schubert	NULL
for	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
;	NULL
and	NULL
Pam	NULL
Stepick-Biek	NULL
and	NULL
Dr.	NULL
Lisa	NULL
Zhou	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Banchereau	NULL
,	NULL
J	NULL
.	NULL

1995	NULL
.	NULL

Converging	NULL
and	NULL
diverging	NULL
properties	NULL
of	NULL
human	NULL
interleukin-4	NULL
and	NULL
interleukin-10	NULL
.	NULL

Behring	NULL
Inst	NULL
.	NULL

Mitt	NULL
.	NULL

96:58	NULL
.	NULL

2	NULL
.	NULL

Reiner	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Seder	NULL
.	NULL

1995	NULL
.	NULL

T	NULL
helper	NULL
cell	NULL
differentiation	NULL
in	NULL
immune	NULL
response	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7:360	NULL
.	NULL

3	NULL
.	NULL

Finkelman	NULL
,	NULL
F.	NULL
D.	NULL
1995	NULL
.	NULL

Relationships	NULL
among	NULL
antigen	NULL
presentation	NULL
,	NULL
cytokines	NULL
,	NULL
immune	NULL
deviation	NULL
,	NULL
and	NULL
autoimmune	NULL
disease	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:279	NULL
.	NULL

4	NULL
.	NULL

Szabo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
L.	NULL
H.	NULL
Glimcher	NULL
,	NULL
and	NULL
I.	NULL
C.	NULL
Ho	NULL
.	NULL

1997	NULL
.	NULL

Genes	NULL
that	NULL
regulate	NULL
interleukin-4	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9:776	NULL
.	NULL

5	NULL
.	NULL

Abmed	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Gray	NULL
.	NULL

1996	NULL
.	NULL

Immunological	NULL
memory	NULL
and	NULL
protective	NULL
immunity	NULL
:	NULL
understanding	NULL
their	NULL
relation	NULL
.	NULL

Science	NULL
272:54	NULL
.	NULL

6	NULL
.	NULL

Swain	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
A.	NULL
D.	NULL
Weinberg	NULL
,	NULL
and	NULL
M.	NULL
English	NULL
.	NULL

1990	NULL
.	NULL

CD4*	NULL
T	NULL
cell	NULL
subsets	NULL
:	NULL
lymphokine	NULL
secretion	NULL
of	NULL
memory	NULL
cells	NULL
and	NULL
of	NULL
effector	NULL
cells	NULL
that	NULL
develop	NULL
from	NULL
precursors	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:1788	NULL
.	NULL

7	NULL
.	NULL

Lewis	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
K.	NULL
S.	NULL
Prickett	NULL
,	NULL
A.	NULL
Larsen	NULL
,	NULL
K.	NULL
Grabstein	NULL
,	NULL
M.	NULL
Weaver	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Wilson	NULL
.	NULL

1988	NULL
.	NULL

Restricted	NULL
production	NULL
of	NULL
interleukin	NULL
4	NULL
by	NULL
activated	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:9743	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

869	NULL
.	NULL

Weinberg	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
M.	NULL
English	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Swain	NULL
.	NULL

1990	NULL
.	NULL

Distinct	NULL
regulation	NULL
of	NULL
lymphokine	NULL
production	NULL
is	NULL
found	NULL
in	NULL
fresh	NULL
versus	NULL
in	NULL
vitro	NULL
primed	NULL
murine	NULL
helper	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:1800.	NULL
.	NULL

Ehlers	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Smith	NULL
.	NULL

1991	NULL
.	NULL

Differentiation	NULL
of	NULL
T	NULL
cell	NULL
lymphokine	NULL
gene	NULL
expression	NULL
:	NULL
the	NULL
in	NULL
vitro	NULL
acquisition	NULL
of	NULL
T	NULL
cell	NULL
memory	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:25	NULL
.	NULL

Brorson	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
B.	NULL
Beverly	NULL
,	NULL
S.	NULL
M.	NULL
Kang	NULL
,	NULL
M.	NULL
Lenardo	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1991	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
nontransformed	NULL
T	NULL
cells	NULL
.	NULL

Apparent	NULL
constitutive	NULL
signals	NULL
in	NULL
run-on	NULL
assays	NULL
can	NULL
be	NULL
caused	NULL
by	NULL
repeat	NULL
sequences	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:3601	NULL
.	NULL

Rao	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factors	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
:	NULL
regulation	NULL
and	NULL
function	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:707	NULL
.	NULL

McCaifftey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
A.	NULL
M.	NULL
Ho	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
J.	NULL
N.	NULL
Lambert	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
G.	NULL
L.	NULL
Verdine	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
cyclosporin-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
262:750	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
369:497	NULL
.	NULL

Hoey	NULL
,	NULL
T.	NULL
,	NULL
Y.	NULL
L.	NULL
Sun	NULL
,	NULL
K.	NULL
Williamson	NULL
,	NULL
and	NULL
X.	NULL
Xu	NULL
.	NULL

1995	NULL
.	NULL

Isolation	NULL
of	NULL
two	NULL
new	NULL
members	NULL
of	NULL
the	NULL
NF-AT	NULL
gene	NULL
family	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-AT	NULL
proteins	NULL
.	NULL

Immunity	NULL
2:461	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
F.	NULL
Saito	NULL
,	NULL
C.	NULL
Hannum	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1995	NULL
.	NULL

NFATx	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
family	NULL
that	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2697	NULL
.	NULL

Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
X.	NULL
Li	NULL
,	NULL
U.	NULL
Francke	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1995	NULL
.	NULL

NFATc3	NULL
,	NULL
a	NULL
lymphoid-specific	NULL
NFATc	NULL
family	NULL
member	NULL
that	NULL
is	NULL
calcium-regulated	NULL
and	NULL
exhibits	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:19898	NULL
.	NULL

Amasaki	NULL
,	NULL
Y.	NULL
,	NULL
E.	NULL
S.	NULL
Masuda	NULL
,	NULL
R.	NULL
Imamura	NULL
,	NULL
K-L.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1998	NULL
.	NULL

Distinct	NULL
NFAT	NULL
family	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
nuclear	NULL
NFAT-DNA	NULL
binding	NULL
complexes	NULL
from	NULL
human	NULL
thymocyte	NULL
subsets	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:2324	NULL
.	NULL

Luo	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Carew	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

Recombinant	NULL
NFAT1	NULL
(	NULL
NFATp	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
calcineurin	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
mediates	NULL
transcription	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:3955	NULL
.	NULL

Shibasaki	NULL
,	NULL
F.	NULL
,	NULL
E.	NULL
R.	NULL
Price	NULL
,	NULL
D.	NULL
Milan	NULL
,	NULL
and	NULL
F.	NULL
McKeon	NULL
.	NULL

1996	NULL
.	NULL

Role	NULL
of	NULL
kinases	NULL
and	NULL
the	NULL
phosphatase	NULL
calcineurin	NULL
in	NULL
the	NULL
nuclear	NULL
shuttling	NULL
of	NULL
transcription	NULL
factor	NULL
NF-AT4	NULL
.	NULL

Nature	NULL
382:370	NULL
.	NULL

Dolganov	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Bort	NULL
,	NULL
M.	NULL
Loveft	NULL
,	NULL
J.	NULL
Burr	NULL
,	NULL
L.	NULL
Schubert	NULL
,	NULL
D.	NULL
Short	NULL
,	NULL
M.	NULL
McGurn	NULL
,	NULL
C.	NULL
Gibson	NULL
,	NULL
and	NULL
D.	NULL
B.	NULL
Lewis	NULL
.	NULL

1996	NULL
.	NULL

Coexpression	NULL
of	NULL
the	NULL
interleukin-13	NULL
and	NULL
interleukin-4	NULL
genes	NULL
correlates	NULL
with	NULL
their	NULL
physical	NULL
linkage	NULL
in	NULL
the	NULL
cytokine	NULL
gene	NULL
cluster	NULL
on	NULL
human	NULL
chromosome	NULL
5q23-31	NULL
.	NULL

Blood	NULL
87:3316	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
.	NULL

1987	NULL
.	NULL

Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
;	NULL
156	NULL
.	NULL

Elson	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
T.	NULL
B.	NULL
Nutman	NULL
,	NULL
D.	NULL
D.	NULL
Metcalfe	NULL
,	NULL
and	NULL
C.	NULL
Prussin	NULL
.	NULL

1995	NULL
.	NULL

Flow	NULL
cyto-metric	NULL
analysis	NULL
for	NULL
cytokine	NULL
production	NULL
identifies	NULL
T	NULL
helper	NULL
1	NULL
,	NULL
T	NULL
helper	NULL
2	NULL
,	NULL
and	NULL
T	NULL
helper	NULL
0	NULL
cells	NULL
within	NULL
the	NULL
human	NULL
CD4	NULL
*	NULL
CD27~	NULL
lymphocyte	NULL
subpopulation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:4294	NULL
.	NULL

Brunvand	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
A.	NULL
Krumm	NULL
,	NULL
and	NULL
M.	NULL
Groudine	NULL
.	NULL

1993	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
reveals	NULL
a	NULL
nuclear	NULL
factor	NULL
bound	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:4824	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
.	NULL

Maxam	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1980	NULL
.	NULL

Sequencing	NULL
end-labeled	NULL
DNA	NULL
with	NULL
base-specific	NULL
chemical	NULL
cleavages	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

65:499	NULL
.	NULL

Mueller	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
B.	NULL
Wold	NULL
.	NULL

1989	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
a	NULL
muscle	NULL
specific	NULL
enhancer	NULL
by	NULL
ligation	NULL
mediated	NULL
PCR	NULL
.	NULL

Science	NULL
246:780	NULL
.	NULL

Schubert	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
G.	NULL
King	NULL
,	NULL
R.	NULL
Q.	NULL
Crom	NULL
,	NULL
D.	NULL
B.	NULL
Lewis	NULL
,	NULL
A.	NULL
Aruffo	NULL
,	NULL
and	NULL
D.	NULL
Hollenbaugh	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
human	NULL
gp39	NULL
promoter	NULL
.	NULL

Two	NULL
distinct	NULL
nuclear	NULL
factors	NULL
of	NULL
activated	NULL
T	NULL
cell	NULL
protein-binding	NULL
elements	NULL
contribute	NULL
independently	NULL
to	NULL
transcriptional	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:29624	NULL
.	NULL

Sicbenlist	NULL
,	NULL
U.	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
C.	NULL
A.	NULL
Norris	NULL
,	NULL
M.	NULL
Kamoun	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Kant	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1986	NULL
.	NULL

Promoter	NULL
region	NULL
of	NULL
interleukin-2	NULL
gene	NULL
undergoes	NULL
chromatin	NULL
structure	NULL
changes	NULL
and	NULL
confers	NULL
inducibility	NULL
on	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
during	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:3042	NULL
.	NULL

Geballe	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Mocarski	NULL
.	NULL

1988	NULL
.	NULL

Translational	NULL
control	NULL
of	NULL
cytomegalo-virus	NULL
gene	NULL
expression	NULL
is	NULL
mediated	NULL
by	NULL
upstream	NULL
AUG	NULL
codons	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:3334	NULL
.	NULL

Petrak	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
A.	NULL
Memon	NULL
,	NULL
M.	NULL
J.	NULL
Birrer	NULL
,	NULL
J.	NULL
D.	NULL
Ashwell	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Zacharchuk	NULL
.	NULL

1994	NULL
.	NULL

Dominant	NULL
negative	NULL
mutant	NULL
of	NULL
c-Jun	NULL
inhibits	NULL
NF-AT	NULL
transcriptional	NULL
activity	NULL
and	NULL
prevents	NULL
IL-2	NULL
gene	NULL
transcription	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:2046	NULL
.	NULL

Kunkel	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
J.	NULL
D.	NULL
Roberts	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Zakour	NULL
.	NULL

1987	NULL
.	NULL

Rapid	NULL
and	NULL
efficient	NULL
site-specific	NULL
mutagenesis	NULL
without	NULL
phenotypic	NULL
selection	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

154:367	NULL
.	NULL

Cron	NULL
,	NULL
R.	NULL
Q.	NULL
,	NULL
L.	NULL
A.	NULL
Schubert	NULL
,	NULL
D.	NULL
B.	NULL
Lewis	NULL
,	NULL
and	NULL
C.	NULL
C.	NULL
W.	NULL
Hughes	NULL
.	NULL

1997	NULL
.	NULL

Consistent	NULL
transient	NULL
transfection	NULL
of	NULL
DNA	NULL
into	NULL
non-transformed	NULL
human	NULL
and	NULL
murine	NULL
T-lym-phocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
205:145	NULL
.	NULL

Hughes	NULL
,	NULL
C.	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Pober	NULL
.	NULL

1996	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
in	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
:	NULL
convergence	NULL
of	NULL
co-stimulatory	NULL
signals	NULL
and	NULL
differences	NULL
from	NULL
transformed	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
:	NULL
5369	NULL
.	NULL

Prasher	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
V.	NULL
K.	NULL
Eckenrode	NULL
,	NULL
W.	NULL
W.	NULL
Ward	NULL
,	NULL
F.	NULL
G.	NULL
Prendergast	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Cormier	NULL
.	NULL

1992	NULL
.	NULL

Primary	NULL
structure	NULL
of	NULL
the	NULL
Aequorea	NULL
victoria	NULL
green-fluorescent	NULL
protein	NULL
.	NULL

Gene	NULL
111:229	NULL
.	NULL

Chalfic	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Tu	NULL
,	NULL
G.	NULL
Euskirchen	NULL
,	NULL
W.	NULL
W.	NULL
Ward	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Prasher	NULL
.	NULL

1994	NULL
.	NULL

Green	NULL
fluorescent	NULL
protein	NULL
as	NULL
a	NULL
marker	NULL
for	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
263:802	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
870	NULL
36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

Penix	NULL
,	NULL
L.	NULL
,	NULL
W.	NULL
M.	NULL
Weaver	NULL
,	NULL
Y.	NULL
Pang	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Wilson	NULL
.	NULL

1993	NULL
.	NULL

Two	NULL
essential	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
interferon	NULL
-y	NULL
promoter	NULL
confer	NULL
activation	NULL
specific	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1483	NULL
.	NULL

Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1994	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFATp	NULL
in	NULL
a	NULL
neuronal	NULL
cell	NULL
line	NULL
and	NULL
in	NULL
the	NULL
murine	NULL
nervous	NULL
system	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:28181	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
J.	NULL
Liu	NULL
,	NULL
R.	NULL
Imamura	NULL
,	NULL
S.	NULL
I	NULL
Imai	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1997	NULL
.	NULL

Control	NULL
of	NULL
NFATx1	NULL
nuclear	NULL
translocation	NULL
by	NULL
a	NULL
calcineurin-regulated	NULL
inhibitory	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:2066	NULL
.	NULL

Arai	NULL
,	NULL
N.	NULL
,	NULL
D.	NULL
Nomura	NULL
,	NULL
D.	NULL
Villaret	NULL
,	NULL
R.	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
M	NULL
.	NULL

Seiki	NULL
.	NULL

,	NULL
M.	NULL
Yoshida	NULL
,	NULL
S.	NULL
Minoshima	NULL
,	NULL
R.	NULL
Fukuyama	NULL
,	NULL
M.	NULL
Mackawa	NULL
,	NULL
J.	NULL
Kudoh	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
.	NULL

Complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
chromosomal	NULL
gene	NULL
for	NULL
human	NULL
IL-4	NULL
and	NULL
its	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:274	NULL
.	NULL

Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
L.	NULL
C.	NULL
Sambucetti	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
R.	NULL
J.	NULL
Distel	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Spiegelman	NULL
.	NULL

1988	NULL
.	NULL

Common	NULL
DNA	NULL
binding	NULL
site	NULL
for	NULL
Fos	NULL
protein	NULL
complexes	NULL
and	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

Cell	NULL
52:471	NULL
.	NULL

Loh	NULL
,	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Carew	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

T-cell	NULL
receptor	NULL
stimulation	NULL
elicits	NULL
an	NULL
early	NULL
phase	NULL
of	NULL
activation	NULL
and	NULL
a	NULL
later	NULL
phase	NULL
of	NULL
deactivation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:3945	NULL
.	NULL

Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
J.	NULL
IL	NULL
Healy	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
C.	NULL
C.	NULL
Goodnow	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1997	NULL
.	NULL

Redundant	NULL
expression	NULL
but	NULL
selective	NULL
utilization	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
family	NULL
members	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:2735	NULL
.	NULL

Beckman	NULL
,	NULL
I.	NULL
,	NULL
K.	NULL
Shepherd	NULL
,	NULL
K.	NULL
Dimopoulos	NULL
,	NULL
M.	NULL
Ahern	NULL
,	NULL
F.	NULL
Firgaira	NULL
,	NULL
and	NULL
J.	NULL
Bradley	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
expression	NULL
and	NULL
regulation	NULL
of	NULL
cytokine	NULL
mRNAs	NULL
in	NULL
normal	NULL
human	NULL
CD45R	NULL
T	NULL
cell	NULL
subsets	NULL
.	NULL

Cytokine	NULL
6:116	NULL
.	NULL

Sanders	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
M.	NULL
W.	NULL
Makgoba	NULL
,	NULL
S.	NULL
O.	NULL
Sharrow	NULL
,	NULL
D.	NULL
Stephany	NULL
,	NULL
T.	NULL
A.	NULL
Springer	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
and	NULL
S.	NULL
Shaw	NULL
.	NULL

1988	NULL
.	NULL

Human	NULL
memory	NULL
T	NULL
lymphocytes	NULL
express	NULL
increased	NULL
levels	NULL
of	NULL
three	NULL
cell	NULL
adhesion	NULL
molecules	NULL
(	NULL
LFA-3	NULL
,	NULL
CD2	NULL
,	NULL
and	NULL
LFA-1	NULL
)	NULL
and	NULL
three	NULL
other	NULL
molecules	NULL
(	NULL
UCHL1	NULL
,	NULL
CDw29	NULL
,	NULL
and	NULL
Pgp-1	NULL
)	NULL
and	NULL
have	NULL
enhanced	NULL
IFN-y	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140	NULL
:	NULL
1401	NULL
.	NULL

Andersson	NULL
,	NULL
U.	NULL
,	NULL
J.	NULL
Andersson	NULL
,	NULL
A.	NULL
Lindfors	NULL
,	NULL
K.	NULL
Wagner	NULL
,	NULL
G.	NULL
Moller	NULL
,	NULL
and	NULL
C.	NULL
H.	NULL
Heusser	NULL
.	NULL

1990	NULL
.	NULL

Simultaneous	NULL
production	NULL
of	NULL
interleukin	NULL
2	NULL
,	NULL
interleukin	NULL
4	NULL
and	NULL
interferon-y	NULL
by	NULL
activated	NULL
human	NULL
blood	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20:1591	NULL
.	NULL

Bucy	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
L.	NULL
Karr	NULL
,	NULL
G.	NULL
Q.	NULL
Huang	NULL
,	NULL
J.	NULL
Li	NULL
,	NULL
D.	NULL
Carter	NULL
,	NULL
K.	NULL
Honjo	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Lemons	NULL
,	NULL
K.	NULL
M.	NULL
Murphy	NULL
,	NULL
and	NULL
C.	NULL
T.	NULL
Weaver	NULL
.	NULL

1995	NULL
.	NULL

Single	NULL
cell	NULL
analysis	NULL
of	NULL
cytokine	NULL
gene	NULL
coexpression	NULL
during	NULL
CD4	NULL
*	NULL
T-cell	NULL
phenotype	NULL
development	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7565	NULL
.	NULL

Abe	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
R.	NULL
De-Waal	NULL
,	NULL
I.	NULL
Matsuda	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1992	NULL
.	NULL

An	NULL
11-base-pair	NULL
DNA	NULL
sequence	NULL
motif	NULL
apparently	NULL
unique	NULL
to	NULL
the	NULL
human	NULL
interleukin	NULL
4	NULL
gene	NULL
confers	NULL
responsiveness	NULL
to	NULL
T-cell	NULL
activation	NULL
signals	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:2864	NULL
.	NULL

Bruhn	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
J.	NULL
L.	NULL
Boulay	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
dissection	NULL
of	NULL
the	NULL
mouse	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:9707	NULL
.	NULL

Chuypilo	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Schomberg	NULL
,	NULL
R.	NULL
Gerwig	NULL
,	NULL
A.	NULL
Heinfling	NULL
,	NULL
R.	NULL
Reeves	NULL
,	NULL
F.	NULL
Grummit	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1993	NULL
.	NULL

Multiple	NULL
closely-linked	NULL
NFAT/octamer	NULL
and	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
are	NULL
part	NULL
of	NULL
the	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5694	NULL
.	NULL

Kubo	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
L.	NULL
Kincaid	NULL
,	NULL
and	NULL
J.	NULL
T.	NULL
Ransom	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
interleukin-4	NULL
gene	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
unique	NULL
calcineurin-dependent	NULL
transcriptional	NULL
factor	NULL
NF	NULL
(	NULL
P	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:19441	NULL
.	NULL

Szabo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
J.	NULL
S.	NULL
Gold	NULL
,	NULL
T.	NULL
L.	NULL
Murphy	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
controlling	NULL
interleukin-4	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
roles	NULL
for	NULL
NF-Y	NULL
and	NULL
NFATc	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4793	NULL
.	NULL

Todd	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Lederer	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
A.	NULL
H.	NULL
Lichtman	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
interleukin	NULL
4	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
multiple	NULL
promoter	NULL
elements	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:1663	NULL
.	NULL

Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
J.	NULL
W.	NULL
Rooney	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
proximal	NULL
promoter	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
is	NULL
composed	NULL
of	NULL
multiple	NULL
essential	NULL
regulatory	NULL
sites	NULL
that	NULL
bind	NULL
at	NULL
least	NULL
two	NULL
distinct	NULL
factors	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:6397	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1995	NULL
.	NULL

Coordinate	NULL
and	NULL
cooperative	NULL
roles	NULL
for	NULL
NF-AT	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
.	NULL

Immunity	NULL
2:473	NULL
.	NULL

Ho	NULL
,	NULL
I.	NULL
C.	NULL
,	NULL
M.	NULL
R.	NULL
Hodge	NULL
,	NULL
J.	NULL
W.	NULL
Rooney	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
proto-oncogene	NULL
c-maf	NULL
is	NULL
responsible	NULL
for	NULL
tissue-specific	NULL
expression	NULL
of	NULL
interleukin-4	NULL
.	NULL

Cell	NULL
85:973	NULL
.	NULL

Wu	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
E.	NULL
J.	NULL
Lai	NULL
,	NULL
N.	NULL
Huang	NULL
,	NULL
and	NULL
X.	NULL
Wen	NULL
.	NULL

1997	NULL
.	NULL

Oct-1	NULL
and	NULL
CCAAT/enhancer-binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
bind	NULL
to	NULL
overlapping	NULL
elements	NULL
within	NULL
the	NULL
interleukin-8	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:2396	NULL
.	NULL

Li-Weber	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Salgame	NULL
,	NULL
C.	NULL
Hu	NULL
,	NULL
I.	NULL
V.	NULL
Davydov	NULL
,	NULL
O.	NULL
Laur	NULL
,	NULL
S.	NULL
Klevenz	NULL
,	NULL
and	NULL
P.	NULL
H.	NULL
Krammer	NULL
.	NULL

1998	NULL
.	NULL

Th2-specific	NULL
protein/DNA	NULL
interactions	NULL
at	NULL
the	NULL
proximal	NULL
nuclear	NULL
factor-AT	NULL
site	NULL
contribute	NULL
to	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
promoter	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:1380	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
M.	NULL
R.	NULL
Hodge	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
common	NULL
factor	NULL
regulates	NULL
both	NULL
Th1-	NULL
and	NULL
Th2-specific	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:625	NULL
.	NULL

Wenner	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
S.	NULL
J.	NULL
Szabo	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1997	NULL
.	NULL

Identification	NULL
of	NULL
IL-4	NULL
promoter	NULL
elements	NULL
conferring	NULL
Th2-restricted	NULL
expression	NULL
during	NULL
T	NULL
helper	NULL
cell	NULL
subset	NULL
development	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:765	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

NFAT	NULL
ENHANCES	NULL
IL-4	NULL
IN	NULL
PRIMED	NULL
CD4	NULL
T	NULL
CELLS	NULL
Rincon	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
mediated	NULL
by	NULL
NFAT	NULL
is	NULL
highly	NULL
inducible	NULL
in	NULL
effector	NULL
CD4	NULL
*	NULL
T	NULL
helper	NULL
2	NULL
(	NULL
Th2	NULL
)	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Th1	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:1522	NULL
.	NULL

Lyakh	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1997	NULL
.	NULL

Expression	NULL
of	NULL
NFAT-family	NULL
proteins	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:2475	NULL
.	NULL

Shaw	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
A.	NULL
M.	NULL
Ho	NULL
,	NULL
A.	NULL
Raghavan	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
J	NULL
.	NULL

Park	NULL
,	NULL
S.	NULL
Sharma	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1995	NULL
.	NULL

Immunosuppressive	NULL
drugs	NULL
prevent	NULL
a	NULL
rapid	NULL
dephosphorylation	NULL
of	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
in	NULL
stimulated	NULL
immune	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:11205	NULL
.	NULL

Choi	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
R.	NULL
D.	NULL
Brines	NULL
,	NULL
M.	NULL
J.	NULL
Holman	NULL
,	NULL
and	NULL
G.	NULL
G.	NULL
Klaus	NULL
.	NULL

1994	NULL
.	NULL

Induction	NULL
of	NULL
NFE-AT	NULL
in	NULL
normal	NULL
B	NULL
lymphocytes	NULL
by	NULL
anti-immunoglobulin	NULL
or	NULL
CD40	NULL
ligand	NULL
in	NULL
conjunction	NULL
with	NULL
IL-4	NULL
.	NULL

Immunity	NULL
1:179	NULL
.	NULL

Luo	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

Mechanisms	NULL
of	NULL
transactivation	NULL
by	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells-1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:141	NULL
.	NULL

Zhang	NULL
,	NULL
Y.	NULL
,	NULL
K.	NULL
H.	NULL
Rogers	NULL
,	NULL
and	NULL
D.	NULL
B.	NULL
Lewis	NULL
.	NULL

1996	NULL
.	NULL

B2-Microglobulin-dependent	NULL
T	NULL
cells	NULL
are	NULL
dispensable	NULL
for	NULL
allergen-induced	NULL
T	NULL
helper	NULL
2	NULL
responses	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1507	NULL
.	NULL

Abbas	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
K.	NULL
M.	NULL
Murphy	NULL
,	NULL
and	NULL
A.	NULL
Sher	NULL
.	NULL

1996	NULL
.	NULL

Functional	NULL
diversity	NULL
of	NULL
helper	NULL
T	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
383:787	NULL
.	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Avots	NULL
,	NULL
and	NULL
M.	NULL
Neumann	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
architecture	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
:	NULL
a	NULL
reflection	NULL
of	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1263:181	NULL
.	NULL

Riegel	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
B.	NULL
Corthesy	NULL
,	NULL
W.	NULL
M.	NULL
Flanagan	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1992	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
.	NULL

Chem	NULL
.	NULL

Immunol	NULL
.	NULL

5:266	NULL
.	NULL

Neumann	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Grieshammer	NULL
,	NULL
S.	NULL
Chuypilo	NULL
,	NULL
B.	NULL
Kneitz	NULL
,	NULL
M.	NULL
Lohoff	NULL
,	NULL
A.	NULL
Schimpl	NULL
,	NULL
B.	NULL
R.	NULL
J.	NULL
Franza	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1995	NULL
.	NULL

RelA/p65	NULL
is	NULL
a	NULL
molecular	NULL
target	NULL
for	NULL
the	NULL
immunosuppressive	NULL
action	NULL
of	NULL
protein	NULL
kinase	NULL
A.	NULL
EMBO	NULL
J	NULL
.	NULL

14:1991	NULL
.	NULL

Garrity	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
D.	NULL
Chen	NULL
,	NULL
E.	NULL
V.	NULL
Rothenberg	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Wold	NULL
.	NULL

1994	NULL
.	NULL

Interleukin-2	NULL
transcription	NULL
is	NULL
regulated	NULL
in	NULL
vivo	NULL
at	NULL
the	NULL
level	NULL
of	NULL
coordinated	NULL
binding	NULL
of	NULL
both	NULL
constitutive	NULL
and	NULL
regulated	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:2159	NULL
.	NULL

Wolfe	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
P.	NULL
Zhou	NULL
,	NULL
V.	NULL
Dotsch	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
A	NULL
.	NULL

You	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
G.	NULL
Wagner	NULL
,	NULL
and	NULL
G.	NULL
L.	NULL
Verdine	NULL
.	NULL

1997	NULL
.	NULL

Unusual	NULL
Rel-like	NULL
architecture	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFATc	NULL
.	NULL

Nature	NULL
385:172	NULL
.	NULL

Zhou	NULL
,	NULL
P.	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

Sun	NULL
,	NULL
V.	NULL
Dotsch	NULL
,	NULL
G.	NULL
Wagner	NULL
,	NULL
and	NULL
G.	NULL
L.	NULL
Verdine	NULL
.	NULL

1998	NULL
.	NULL

Solution	NULL
structure	NULL
of	NULL
the	NULL
core	NULL
NFATC1/DNA	NULL
complex	NULL
.	NULL

Cell	NULL
92:687	NULL
.	NULL

Chen	NULL
,	NULL
L.	NULL
,	NULL
N.	NULL
M.	NULL
Glover	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Harrison	NULL
.	NULL

1998	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
DNA-binding	NULL
domains	NULL
from	NULL
NFAT	NULL
,	NULL
fos	NULL
and	NULL
jun	NULL
bound	NULL
specifically	NULL
to	NULL
DNA	NULL
.	NULL

Nature	NULL
392:42	NULL
.	NULL

Takemoto	NULL
,	NULL
N.	NULL
,	NULL
N.	NULL
Koyano-Nakagawa	NULL
,	NULL
N	NULL
.	NULL

Arai	NULL
.	NULL

,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
T.	NULL
Yokota	NULL
.	NULL

1997	NULL
.	NULL

Four	NULL
P-like	NULL
elements	NULL
are	NULL
required	NULL
for	NULL
optimal	NULL
transcription	NULL
of	NULL
the	NULL
mouse	NULL
IL-4	NULL
gene	NULL
:	NULL
involvement	NULL
of	NULL
a	NULL
distinct	NULL
set	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
activator	NULL
protein-1	NULL
family	NULL
proteins	NULL
.	NULL

Inf	NULL
.	NULL

Immunol	NULL
.	NULL

9:1329	NULL
.	NULL

Aune	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1997	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
transcription	NULL
directed	NULL
by	NULL
a	NULL
discrete	NULL
NF-AT	NULL
binding	NULL
element	NULL
from	NULL
the	NULL
IL-4	NULL
promoter	NULL
in	NULL
naive	NULL
and	NULL
effector	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:36	NULL
.	NULL

Tara	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
L.	NULL
Weiss	NULL
,	NULL
and	NULL
M.	NULL
A	NULL
.	NULL

Brown	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
constitutive	NULL
and	NULL
inducible	NULL
components	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
IL-4	NULL
activation	NULL
responsive	NULL
element	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:4592	NULL
.	NULL

Beals	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
C.	NULL
M.	NULL
Sheridan	NULL
,	NULL
C.	NULL
W.	NULL
Turck	NULL
,	NULL
P.	NULL
Gardner	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
export	NULL
of	NULL
NF-ATc	NULL
enhanced	NULL
by	NULL
glycogen	NULL
synthase	NULL
kinase-3	NULL
.	NULL

Science	NULL
275:1930	NULL
.	NULL

Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
H.	NULL
J.	NULL
Chun	NULL
,	NULL
J.	NULL
Rengarajan	NULL
,	NULL
A.	NULL
Alt	NULL
,	NULL
R.	NULL
Lieberson	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1996	NULL
.	NULL

NE-AT-driven	NULL
interleukin-4	NULL
transcription	NULL
potentiated	NULL
by	NULL
NIP45	NULL
.	NULL

Science	NULL
274:1903	NULL
.	NULL

Zheng	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
Th2	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
89:587	NULL
.	NULL

Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
A.	NULL
M.	NULL
Ranger	NULL
,	NULL
F.	NULL
Charles	NULL
de	NULL
la	NULL
Brousse	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1996	NULL
.	NULL

Hyperproliferation	NULL
and	NULL
dysregulation	NULL
of	NULL
IL-4	NULL
expression	NULL
in	NULL
NF-ATp-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
4:397	NULL
.	NULL

Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
Viola	NULL
,	NULL
K.	NULL
T.	NULL
Shaw	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
J.	NULL
D.	NULL
Wallace	NULL
,	NULL
P.	NULL
T.	NULL
Bozza	NULL
,	NULL
D.	NULL
C.	NULL
Luk	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
enhanced	NULL
immune	NULL
response	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
.	NULL

Science	NULL
272:892	NULL
.	NULL

Schuh	NULL
,	NULL
K.	NULL
,	NULL
B.	NULL
Kneitz	NULL
,	NULL
J.	NULL
Heyer	NULL
,	NULL
F.	NULL
Sicbelt	NULL
,	NULL
C.	NULL
Fischer	NULL
,	NULL
E.	NULL
Jankevics	NULL
,	NULL
E.	NULL
Rude	NULL
,	NULL
E.	NULL
Schmitt	NULL
,	NULL
A.	NULL
Schimpl	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1997	NULL
.	NULL

NF-ATp	NULL
plays	NULL
a	NULL
prominent	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
Th2-type	NULL
lymphokines	NULL
.	NULL

Immunol	NULL
.	NULL

Lett	NULL
.	NULL

57:171	NULL
.	NULL

Nonoyama	NULL
,	NULL
S.	NULL
,	NULL
L.	NULL
A.	NULL
Penix	NULL
,	NULL
C.	NULL
P.	NULL
Edwards	NULL
,	NULL
D.	NULL
B.	NULL
Lewis	NULL
,	NULL
S.	NULL
Ito	NULL
,	NULL
A.	NULL
Aruffo	NULL
,	NULL
C.	NULL
B.	NULL
Wilson	NULL
,	NULL
and	NULL
H.	NULL
D.	NULL
Ochs	NULL
.	NULL

1995	NULL
.	NULL

Diminished	NULL
expression	NULL
of	NULL
CD40	NULL
ligand	NULL
by	NULL
activated	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

95:66	NULL
.	NULL

Kiani	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
P.	NULL
B.	NULL
Viola	NULL
,	NULL
A.	NULL
H.	NULL
Lichtman	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1997	NULL
.	NULL

Down-regulation	NULL
of	NULL
IL-4	NULL
gene	NULL
transcription	NULL
and	NULL
control	NULL
of	NULL
Th2	NULL
cell	NULL
differentiation	NULL
by	NULL
a	NULL
mechanism	NULL
involving	NULL
NFAT1	NULL
.	NULL

Immunity	NULL
7:849	NULL
.	NULL

Viola	NULL
,	NULL
J.	NULL
P.	NULL
B.	NULL
,	NULL
A.	NULL
Kiani	NULL
,	NULL
P.	NULL
T.	NULL
Bozza	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
allergic	NULL
inflammation	NULL
and	NULL
eosinophil	NULL
recruitment	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
:	NULL
role	NULL
of	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
and	NULL
IL-5	NULL
.	NULL

Blood	NULL
91:2223	NULL
.	NULL

Heyer	NULL
,	NULL
J.	NULL
,	NULL
B.	NULL
Kneitz	NULL
,	NULL
K.	NULL
Schuh	NULL
,	NULL
E.	NULL
Jankevics	NULL
,	NULL
F.	NULL
Sicbelt	NULL
,	NULL
A.	NULL
Schimpl	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1997	NULL
.	NULL

Incfficient	NULL
termination	NULL
of	NULL
antigen	NULL
responses	NULL
in	NULL
NF-ATp-deficient	NULL
mice	NULL
.	NULL

Immunobiology	NULL
198:162	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

